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Abstract. 
 
Extracellular vesicles (EVs) are small, membranous entities secreted from most 
eukaryotic cells at both homeostatic and stress conditions. Carrying active biological 
molecules – nucleic acids, lipids and proteins – EVs serve as important means of 
intercellular communication. In the immune system, EVs circulting in body fluids play 
important modulatory roles in coordination of responses. EVs are integral part of 
secretome – all proteins secreted by cells. EVs provide means for secretion of proteins 
that are not trafficked through conventional, ER/Golgi-mediated mechanisms. Analysis of 
EV proteome provides basis for fundamental discoveries in understanding the biogenesis, 
secretion and delivery of these nanosized messengers to target cells. 
Macrophages are principal tissue-resident effector cells of innate immune system, 
performing surveillance of their neighborhood in search for danger. Macrophages express 
pattern recognition receptors (PRRs) which recognize conserved pathogen-associated 
molecular patterns (PAMPs) – conserved range of molecules expressed by pathogens. 
PRRs also recognize endogeneous ligands that appear in the human body in other 
dangerous conditions and diseases. These are collectively called danger-associated 
molecular patterns (DAMPs). Recognition of PAMPs and DAMPs by PRRs triggers 
intracellular signaling, leading to activation of macrophage defense mechanisms. These 
begin with inflammation and secretion of pro-inflammatory cytokines, but many other 
proteins are also actively secreted by activated macrophages. Although inflammatory 
cytokine secretion is a well-studied process, very few studies investigating overall and 
EV-mediated protein secretion from human macrophages were performed. 
This thesis aims at broadening our understanding of EV-mediated protein secretion 
from human macrophages activated in response to selected innate immune activators, 
namely extracellular adenosine triphosphate (ATP), a potent DAMP released during cell 
damage; (1,3)-β-glucan, a polysaccharide component of fungal cell wall, activating 
dectin-1-mediated signaling and influenza A virus (IAV) - common seasonal pathogenic 
virus targeting lung epithelia and macrophages. Total secretome and purified EVs were 
analyzed using different high-throughput mass spectrometry-based methods and further 
explored using bioinformatic and biochemical studies. 
The presented results provide evidence that EV-mediated protein secretion is an 
integral part of responses of human macrophages to studied stimuli. Its activation is 
demonstrated with quantitative and comparative proteomic approaches. The secreted 
vesicles are characterized by a broad size range consistent with both exosomes and 
microvesicles, demonstrating that both types of vesicular structures are involved in 
protein secretion. The EVs carry distinct set of immunologically important proteins, and 
bioinformatic analysis suggests that the secreted EVs may exert immunomodulatory 
effects on recipient cells. It is shown that during IAV infection, EVs are mediators of pro-
inflammatory and antiviral cytokine release, thus they may serve as protective capsules of 
targeted cytokine delivery. Proteomic analysis identified also a broad set of DAMPs 
unconventionally secreted in association with EVs, further extrapolating their function 
towards danger signaling in cellular immune responses. The study on ATP-mediated 
responses further investigates the intracellular signaling involving calpains, abundant 
 
 
cytosolic proteases, identifying their crucial roles downstream P2X7 receptor: in EV 
release, as well as inflammasome activation and IL-1β secretion. 
The data presented here indicate that EVs serve as unconventional means for 
secretion of a broad range of proteins secreted in PRR-mediated responses in human 
macrophages. Bioinformatic and functional analysis identifies potential processes 
involved in their generation as well as their roles in intercellular communication. 
Together, the presented thesis contributes to our understanding of unconventional, 
EV-mediated protein secretion in macrophage responses towards common, 
physiologically releveant threats. The studies presented here will serve as basis for further 
detailed functional analysis of the roles of EVs in communication between macrophages 
and other immune system cells. It will also lay the grounds for future studies involving 
EV-mediated macrophage responses in patients with fungal and viral infections. 
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Introduction. 
 
1. Human immune system and innate immunity. 
 
Humans encounter all kinds of microorganisms at any time of their lives, many of 
them considered pathogenic, i.e. capable of causing harmful effect on the organism. The 
immune system collectively describes various mechanisms through which human 
organism prevents unwanted and pathogenic microorganisms from entering and surviving 
in the body. It is commonly divided into two main subsystems: innate and adaptive 
immunity. Innate immune system has an intrinsic capability of detection of invading 
microbes and provides immediate protection at any stage of life. In contrast, adaptive 
immunity evolves constantly during lifetime along with gradual immunogenic challenges 
encountered, featuring immunological memory. Adaptive immune responses vary among 
individuals and are a subject of targeted manipulation, by e.g. vaccination. Adaptive 
immune system is capable of developing specific responses that allow for extremely 
efficient elimination of highly disseminated systemic infections, but its full-extent 
activation takes place much later, within days after pathogen encounter. Before that 
happens, the innate immune system is mainly responsible for counteracting the 
developing infection. 
 
1.1 Innate immunity and activation of adaptive immune responses. 
 
In humans, physical and chemical barriers, like skin, mucous membranes, and 
gastric acids protect the body against most of the microorganisms present in the 
environment. If a pathogen is able to cross through these barriers, innate immunity 
provides the first line of defense against it. The ancient innate immune system, provides a 
person with a range of basic tools capable of immediate, pattern-based, unspecific 
detection and elimination of the intruder. 
Body surfaces and epithelia are coated with molecules providing immediate 
protection. Antimicrobial peptides provide rapid protection against pathogenic bacteria 
and viruses (Bahar and Ren, 2013). These few- to hundreds-amino acid-long peptides 
efficiently penetrate and destroy microbial cell wall. Ancient complement system allows 
for direct destruction of the pathogen. Complement proteins, produced in liver, circulate 
in the blood in inactive form and become activated upon binding to bacterial surface. The 
activated complement components subsequently trigger a cascade of activation of other 
proteins that deposit on the bacterial surface forming pores and causing lysis of the 
microorganism. Complement proteins also possess the opsonization ability, i.e. labeling 
the bacterial surface for phagocytosis. Some complement proteins have pro-inflammatory 
properties. 
Cellular responses are triggered when the pathogen penetrates the body surface to 
establish infection. Cells of the innate immune system are equipped with a broad range of 
pattern recognition receptors (PRRs), which once ligated by a matching component of the 
pathogen that enters the body (called pathogen-associated molecular pattern, PAMP) or 
an endogenous danger signal associated with cell damage (danger-associated molecular 
pattern, DAMP), trigger the activation of the innate immune system. This initial detection 
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and activation of immune cells causes them to begin inflammatory process aiming at 
destroying and preventing further invasion of a pathogen, and mobilizing other cells of 
the immune system to appropriate action. 
The innate immune recognition of pathogens is primarily a role of macrophages, 
dendritic cells and neutrophils. Macrophages reside in the skin, lung epithelia, bones, 
lymph nodes and Peyer’s patches of the intestine. They constitute an important class of 
phagocytic cells, equipped with broad range of PRRs, constantly monitoring the 
environment around them for the presence of PAMPs. Once they detect a pathogen, they 
rapidly secrete cytokines alerting the immune system and boosting their own phagocytic 
activity to clear the pathogen. The roles of macrophages in innate immunity will be 
discussed in greater detail in subsequent sections. Neutrophils, in contrast to 
macrophages, circulate in the blood and are one of the first cell types arriving to the 
infection site. Neutrophils driven by chemokines produced by macrophages gain the 
ability to exit the blood vessels (extravasate) and migrate through the tissue to make 
direct contact with pathogen. They act by direct phagocytosis, secretion of antimicrobial 
granules and pro-inflammatory factors, and formation of neutrophil extracellular traps to 
prevent pathogen spread (Rosales et al, 2016).  
Dendritic cells (DC) are phagocytic cells whose primary function is to activate 
adaptive immune system by antigen presentation. This happens when a DC phagocytoses 
the pathogen, migrates to the lymphoid organ and presents its peptide antigens on major 
histocompatibility complex (MHC) molecules to the naïve T cell, activating the cell-
mediated adaptive immunity. After activation, helper T cells rapidly proliferate and 
circulate through blood and lymphatic vessels in search for more antigen-presenting cells 
to which they can provide help. At the same time adaptive immunity cells evolve and 
gain more specificity and resulting robustness of response against the infection. 
Another important role for antigen-presenting cells is to activate B cells. B cells are 
adaptive immunity cells of lymphoid origin equipped with immunoglobulin receptors (B 
cell receptors), which upon recognition of cognate antigen secrete their receptors in 
soluble form (antibodies) for neutralization and opsonization purposes. Importantly, the 
process of B cell activation requires help from cognate helper T cells.  
Adaptive immune response provides much more specific defense actions targeted 
at particular pathogen that managed to overcome the first lines of defense. It is an 
extremely powerful and sophisticated system equipped with tools capable of eliminating 
invaders, destroying virus-infected cells and cancer cells, neutralizing toxins and 
providing long-lasting protection in a form of immunological memory. 
Macrophages, like DCs, express MHC and are capable of interacting with T cells, 
but since they do not circulate through lymph nodes, their role in activation of adaptive 
immunity is limited to the site of infection. Their role in crosstalk with adaptive immune 
system is to present the MHC-bound antigen to circulating effector T cells to obtain 
necessary help, mainly for tumor necrosis factor (TNF) production and increasing 
phagocytic capability. Helper T cells also provide macrophages with signals for 
production of reactive oxygen species (ROS) and nitric oxide that facilitate efficient 
elimination of phagocytosed microbes.  
The role of innate immune cells is not limited to response to the PAMPs. 
Endogenous components released in abnormal circumstances other than infection (e.g. as 
a result of autoinflammation or tissue damage) are also potent activators of innate 
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immunity. Macrophages play key roles in detection of these signals and restoration of 
homeostasis. 
All cells of the human immune system play important roles and are highly 
dependent on each other, tightly collaborating to regulate the response against any kind of 
danger. This is achieved by direct cell-cell contacts, secretion of soluble signaling 
proteins, called cytokines for their prominent role in modifying behavior of other cells, as 
well as secretion proteins packed in extracellular vesicles (EVs), discussed in greater 
detail in chapters 3 and 4. 
 
 
 
 
 
Figure 1. Overview of human immune system activation. In order to establish the infection, 
the pathogen must cross through physical barriers (including pH gradient, antimicrobial 
peptides and proteases) on the outer surface of the skin or mucus membranes. After 
penetration of physico-chemical barriers it encounters phagocytic cells of innate immune 
system: tissue macrophages and dendritic cells. Macrophages are primarily responsible for 
elimination of the pathogen at the infection site. Dendritic cells phagocytose the pathogen 
and present its components to specific T cell, which subsequently divides rapidly and 
generates a subset of effector T cells that regulate and amplify the immune response. In 
certain cases, DC also activate B cells which differentiate into antibody-secreting plasma 
cells. Antibodies can directly inactivate or opsonize the pathogen. DC thus provide the 
bridging between innate and adaptive immunity. 
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1.2 Macrophages and their roles in human immune system. 
 
Macrophages are specialized leukocytes of monocytic origin. They are long-living, 
professional phagocytes present in all tissues of the human body, constantly “probing” 
their surroundings for the presence of PAMPs and DAMPs. Macrophages maintain 
homeostasis of blood, clearing up to 3.6 x 1011 erythrocytes daily, recycling hemoglobin 
and iron, and removing the cellular debris and apoptotic cells (Bratosin et al, 2001). 
They are equipped with scavenger receptors facilitating clearance of cell debris, apoptotic 
cells and opsonized pathogens. The most prominent roles, however, are played by 
macrophages in the field of immunity. Macrophages are present in submucosal tissues of 
the sites of contact of human body with the external material. They are particularly 
abundant in the bronchi, lung interstitium and gastrointestinal tract, but different forms of 
macrophages exist also e.g. in the brain (microglia) and the liver (Kupffer cells). 
Macrophages express surface-bound, endosomal and soluble cytoplasmic PRRs. 
They ingest large volumes of extracellular fluid as well as other cells and debris in the 
process of macropinocytosis. The ingested material is trafficked through the lysosomal 
pathway for degradation and intracellular detection. When a PAMP is exposed on the 
surface of a pathogen, macrophages can also sense it with a membrane-bound PRR. 
DAMPs, in contrast, appear in the tissue and blood after cell damage without necessary 
participation of exogenous agents. After detection of the PAMP or DAMP, macrophages 
become activated and take various roles in regulation of inflammation and tissue 
regeneration (Murray and Wynn, 2011). Activation response in macrophages depends 
on the encountered ligand and the PRR that detects it. 
PRRs have been classified into 4 broad families based on structure characteristics: 
Toll-like receptors (TLRs), nucleotide-binding domain, leucine-rich repeat containing 
receptors (NLRs), RIG-I-like receptors, and C-type lectin-like receptors (CLRs). These 
receptors have been shown to play fundamental roles in recognition of a variety of 
PAMPs from all pathogen classes (Takeuchi and Akira, 2010). 
TLRs sense various bacterial and viral constitutents, but some play roles in 
recognition of fungal and protozoan PAMPs. In humans, TLRs comprise a family of 10 
transmembrane receptors spanning the cellular membrane as well as membranes of 
intracellular vesicles like endosomes, detecting both extracellular and intracellular 
PAMPs. Signaling through TLRs proceeds through different pathways, leading to 
translocation of appropriate transcription factors to the nucleus. Bacterial PAMPs signal 
through TLRs to activate nuclear factor kappa-B (NFκB) and activator protein 1 (AP-1), 
transcription factors essential for pro-inflammatory cytokine production. Viral PAMPs 
activate also endosomal TLRs, which are capable of activating interferon regulatory 
factor 3 (IRF3), essential for transcription of type I interferons. Activation of transcription 
programs leads to terminal macrophage differentiation and to full capacity in defense 
against encountered danger. 
Classical approaches for classification of macrophages describe M1 and M2 types. 
M1 macrophages develop as a result of PAMP (or DAMP) encounter and are responsible 
for inflammation and phagocytosis of the pathogen. Differentiation into M1 macrophage 
is triggered by ligation of TLRs in the presence of interferon (IFN) γ. They secrete pro-
inflammatory cytokines, which recruit circulating monocytes and stimulate their 
differentiation into macrophages, and participate in defense against extracellular bacteria, 
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protozoa and viruses. In contrast, M2 macrophages can develop in the course of immune 
response via alternative activation. This subset secrets large amounts of anti-
inflammatory and regulatory cytokines (e.g. interleukin (IL) 10 (IL-10)) leading to 
limiting of the inflammation and ultimately tissue regeneration and stabilization (Murray 
and Wynn, 2011). 
Macrophages play important role in maintaining tissue homeostasis. In the lungs, 
for example, alveolar macrophages facilitate clearing of allergens that otherwise may lead 
to the development of inflammation. Macrophages present in the brain (microglia) ensure 
that the inflammatory response to damaged neurons, plaques or in rare cases pathogens is 
quickly contained. 
 
1.2.1. Macrophages in fungal infection. 
 
Fungi are versatile eukaryotes forming a distinct kingdom of organisms. Although 
some are normally present in human body (e.g. candida in female vagina or fungi 
inhabiting the gut), their pathologic colonization is prevented by co-existing bacteria. 
Some fungi, however, possess the ability of existing in various forms (dimorphic fungi) 
and dynamic switching between them, protecting them from bacterial outgrowth and 
providing means for protection from immediate elimination by human immune system. 
The latter is also achieved by the ability to dynamically change the exposed immunogenic 
molecules on their surface. 
Fungal infections remain important threat to public health. Invasive mycoses 
occurrence has been rising since mid-20th-century antibiotic boom due to facilitated 
fungal colonization of patients undergoing antibiotic therapy. Aspergillosis, candidiasis, 
trichosporonosis and fusariosis belong to most common fungi-caused diseases, with 
prevalence among patients undergoing prolonged hospitalizations and anti-HIV therapies, 
including immunosuppression (Park et al, 2011). Fungal infections are also difficult to 
treat because of toxicity associated with many antifungal agents (Odds et al, 2003), while 
no vaccines against fungal pathogens exist. 
Fungal colonizations often limit to mucous membranes of the mouth or skin. More 
serious fungal infections most commonly begin with spore inhalation and colonization of 
mucous membranes of respiratory epithelia. For example, inhaled Aspergillus fumigatus 
spores are capable of changing morphology to hyphal form once they manage to 
overcome the phagocytic action of alveolar macrophages. Increased pathogenicity of 
established mycoses is associated with toxicity of fungal metabolites and mycotoxins. 
Hence, prompt detection and elimination of fungus by macrophages belongs to most 
important immune defense mechanisms preventing lung colonization. This is achieved by 
phagocytosis of invading pathogens and secretion of signaling proteins, recruiting other 
immune cells. 
Macrophages sense multiple PAMPs of fungal pathogens in different 
morphological states. Fungal PAMPs comprise mainly of characteristic glucose-
containing molecules present in fungal cell walls: mannoproteins, β-glucans and chitin 
(Sorrell and Chen, 2009). Two main groups of PRRs are specialized in binding to those 
ligands – TLRs and CLRs. 
 Most of the fungal PAMPs activate multiple receptors, leading to their cross-talk 
and differential signaling modulation. Key feature of fungi sensing by macrophages is a 
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robust secretion of cytokines (TNF and IL-1β). Importantly, it has been shown that Th17 
responses are critical in adaptive immunity against fungi, and that activation of fungal-
components-binding receptors contribute to driving the adaptive response towards Th17 
type (Vautier et al, 2010). 
TLR2 and TLR4, along with other PRRs, have been linked with fungi recognition 
by phagocytic cells, however, the family of CLRs is presently thought to play major roles 
in antifungal response (Kerrigan and Brown, 2011). Outer layer of fungal cell wall is 
typically composed of mannose polymers and mannoproteins (Levitz, 2010). α-Mannans 
have been suggested to be recognized by dectin-2 (Saijo et al, 2010), dectin-3 (Zhu et al, 
2013), mannose receptor (CD206) and DC-SIGN (Levitz and Specht, 2006). 
Important PRR associated with immunity against fungi is the C-type lectin domain 
family 7 member A (dectin-1). This type II membrane receptor is expressed on the 
surface of all antigen presenting cells, and was identified as an essential contributor to 
innate immune recognition of linear 1-3-linked β-glucans component of fungal cell wall 
(Brown and Gordon, 2001). Dectin-1 possesses an immunoreceptor tyrosine-based 
activation motif (ITAM) which is phosphorylated and signals through spleen tyrosine 
kinase (Syk) and mitogen-acticvated protein kinases (MAPK), ultimately activating 
NFκB driving transcription of pro-inflammatory cytokines (see Figure 2). 
 
1.2.2 Macrophages in sensing the extracellular ATP as a DAMP. 
 
Human macrophages do not respond solely to the pathogen presence. In many 
cases they encounter endogenous danger signals (DAMPs) and participate in the response 
to pathologic condition of an organ, tumor development or tissue damage. These can be 
proteins as well as lipids and small molecules. Many of the responses to DAMPs also rely 
on specialized receptors becoming activated by ligation of a DAMP and triggering 
cellular signaling leading to appropriate response. There is, however, speculation that 
PRRs might also contribute to detection of non-microbial DAMPs (Baker et al, 2005). 
Adenosine triphosphate (ATP) is a purine nucleotide, found in all cells and an 
important energy carrier. ATP pool present inside the cell is essential to maintain its 
proper functioning, but occasionally ATP occurs in the extracellular milieu as a result of 
cell damage. Extracellular ATP is quickly hydrolyzed by ecto-apyrases and ecto-ATPases 
(Trautmann, 2009), but in cases of heavy cell damage the amounts of extracellular ATP 
exceeds the normal elimination capacity of the enzymes. In such circumstances, 
extracellular ATP plays a role of important DAMP quickly alerting neighboring cells.  
Sensing extracellular ATP by macrophages is mediated by the P2X family of 
purinergic receptors (purinoceptors), of which P2X7 plays important role. These large, 
multimeric membrane receptors are cation-permeable ligand-gated ion channels 
expressed in most mammalian tissues (North, 2002). Ligation of ATP to the extracellular 
part of purinoceptor triggers a conformational change allowing for passing of small ions 
and hydrophilic molecules of up to 900 Da (Di Virgilio, 1995) through the cellular 
membrane in both directions. The subsequent imbalance of intracellular ions (Ca2+ and 
K+) modulates various signaling pathways. In the case of P2X7, the membrane 
permeability may also be a result of pannexin channel formation (Wiley et al, 2011). 
P2X7 is one of the best characterized receptor in the family, known for prominent 
roles in immunity. P2X7 has been identified as a potent inducer of cytokine IL-1β, an 
7 
 
important mediator of inflammatory responses, proliferation and apoptosis. IL-1β is 
produced in a precursor form, which is processed to the mature, secreted protein by the 
action of caspase-1. P2X7 activation has been shown to lead to maturation and release of 
IL-1β from lipopolysaccharide (LPS)-primed murine macrophages (Perregaux and 
Gabel, 1994, Ferrari et al, 1997). Following studies demonstrated that the P2X7-
induced IL-1β secretion is mediated via NOD-like receptor family member, LRR- and 
pyrin domain-containing (NLRP3) inflammasome, a multiprotein complex recruiting 
caspase-1, an enzyme that is responsible for cleaving the pro-form of IL-1β in the 
maturation step (Martinon et al, 2002). 
Critical roles of P2X7 are not limited to NLRP3 inflammasome activation. 
Signaling through this receptor has also been linked with apoptosis, necrosis, cell 
proliferation (Adinolfi et al, 2015), activation of NFκB (Ferrari et al, 1997), membrane 
blebbing (Qu and Dubyak, 2009) and EV secretion (Qu et al, 2009). 
 
1.2.3 Macrophages in immunity against influenza. 
 
Influenza A virus (IAV) belongs to a genus of Orthomyxoviridae, single-stranded 
negative-sense RNA viruses causing seasonal local outbreaks of infections of varying 
severity around the world, leading to 250,000 to 500,000 deaths annually (Ginsberg et al, 
2009). Rapidly mutating in different vertebrate host reservoirs, IAV remains a threat for 
public health because of occasional emergence of highly pathogenic strains capable of 
causing pandemic outbreak upon cross-species transmission to humans, despite 
widespread vaccination programs. 
IAV spreads to macrophages after crossing the mucous membranes and infecting 
lung epithelial cells. Macrophages found in lungs are heterogeneous, playing both 
regulatory and inflammatory properties. The virus enters the macrophages by binding to 
sialic acid residues with its surface protein hemagglutinin. Additionally, several other 
macrophage surface molecules have been implicated in IAV entry (galactose-type lectin, 
macrophage mannose receptor (Upham et al, 2010, Ng et al, 2014), DC-SIGN and L-
SIGN (Gillespie et al, 2016)). 
Although IAV generally does not cause productive infection in macrophages, it 
may lead to significant depletion of alveolar macrophages and resulting bacterial 
pneumonia, which may turn fatal to the patient (Ghoneim et al, 2013). Macrophages 
respond promptly to the viral infection, regulating cellular response at many levels and 
their early activation is critical for efficient containment of the infection. However, 
researchers have not yet reached a consensus on exact roles of macrophages in the course 
of influenza infection. 
Infected macrophages detect the viral components using several important PRRs. 
Endosomal TLR3, TLR7 and TLR8, capable of detecting viral RNA (as single stranded 
RNA or double-stranded intermediate during replication) have been implicated in 
macrophage response to influenza. Another group of receptors are cytosolic retinoic acid-
inducible gene I-like (RIG-I) and NLRP3. These receptors are activated once the 
influenza components are released into the cytosol of infected cell. 
Activation of innate immune sensors leads to induction of transcription programs 
(particularly NFκB- and IRF3-dependent) and secretion of pro-inflammatory cytokines 
TNF-α, IL-1 and IL-6, as well as type I and III interferons (Iwasaki and Pillai, 2014). 
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Interferons play essential roles in the context of viral infections, helping the infected cells 
to eliminate the virus by activating interferon stimulated genes (ISGs). Induction of ISGs 
allows for combatting the viral infection in multiple ways, e.g. MX1 induction helps 
blocking the viral transcription (Staeheli et al, 1986, Cilloniz et al, 2012), and TRIM22 
targets the nucleocapsid for proteasomal degradation (Di Pietro et al, 2013). 
 
 
 
 
Figure 2. Simplified scheme of macrophage detection of studied PAMPs and DAMPs 
leading to inflammatory response and modulation of classical and non-classical protein 
secretion in human macrophages. PRRs involved in recognition are indicated. Influenza 
viruses target the extracellular receptors to bind and enter the macrophage, but activate the 
immune responses once their RNA is exposed inside the endosomal compartment. Fungal β-
glucan is detected extracellularly by surface-bound dectin-1 and TLRs, thereby triggering 
intracellular signaling. Extracellular ATP activates potassium efflux and calcium influx upon 
activating the P2X7 ion channel, causing activation of calcium-dependent cytoplasmic 
proteases. Presented stimuli lead to inflammasome activation and further secondary 
responses, including EV secretion. 
 
 
Influenza viruses are equipped with molecular mechanisms of counteracting the 
immune response. One of the key virulence factors is the non-structural protein 1 (NS1). 
NS1 is a RNA-binding protein acting both in the nucleus and in the cytosol of the host 
cell. Its prominent role has been associated with inhibition of interferons production. One 
proposed mechanism is preventing the activation of RIG-I and consequent IRF3 
activation (Krug, 2015), but this mechanism has not been demonstrated to be universal to 
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all seasonal influenza A strains (Kuo et al, 2010). Another potential target of NS1 is the 
30 kDa subunit of cellular cleavage and polyadenylation specificity factor, which is 
required for mRNA maturation including antiviral genes and IFN mRNAs (Das et al, 
2008). NS1 is thought to prevent the inhibition of protein synthesis – one of mechanisms 
the infected cell uses to limit viral replication (Krug, 2015). Other roles for NS1 protein 
include prevention of cellular apoptosis, enhancement of viral mRNA transcription and 
translation. Cheong and colleagues suggested a role for NS1 in inhibition of NLRP3 
inflammasome and consequent prevention of IL-1β and IL-18 secretion (Cheong et al, 
2015). Thus, NS1 protein is a multilevel regulator of host cell responses acting in favor of 
the virus inside the infected cell, facilitating viral replication and spreading. 
Figure 2 summarizes the roles of macrophages in detection of the abovementioned 
challenges and activating immune responses leading to unconventional protein secretion 
in the form of membrane vesicles. 
 
2. Protein secretion in eukaryotic cells. 
 
While DNA is a conserved “template” of life as we know it, its end products, 
proteins, can be considered “workhorses” of life. Proteins are constantly expressed by 
living cells and serve purposes in intracellular compartments as well extracellularly. 
Those destined to extracellular medium have to be transported outside the cell in a 
process generally referred to as protein secretion. 
Proteins are secreted from eukaryotic cells in abundance and via different 
mechanisms that are both constitutive and regulated. Protein secretion serves intercellular 
communication. From the viewpoint of immune system, it is important to understand how 
immune cells signal between each other to keep immune responses quick, specific, 
efficient and coordinated. 
Proteins are secreted in two general ways. “Conventional” or “classical” secretion 
refers to process of secretion via the endoplasmic reticulum (ER)/Golgi mechanism. 
Classical secretory mechanism is responsible for secretion of ca 20 % prokaryotic 
(Nielsen et al, 1997) and 20-50 % eukaryotic (Agrawal et al, 2010, Krogh et al, 2001) 
proteins, based on sequence predictions. Classically secreted proteins possess the N-
terminal signal sequence which is recognized by dedicated secretion machinery and 
processed during the secretion. Remaining secreted proteins are incorporated to 
membrane-enclosed compartments and secreted in the form of vesicles. 
 
2.1 Classical secretory pathway 
 
Classical protein secretion mechanism was first described by a Nobel Prize winner 
George Palade in 1975 (Palade, 1975), and refers to the ancient mechanism responsible 
for secretion of proteins by prokaryotic and eukaryotic organisms. Importantly, it also 
encompasses a group of proteins whose faith is not to be secreted into the extracellular 
milieu, but remain attached on the outer side of the cellular membrane or to remain as 
active components of the secretory pathway itself. The classical protein secretion 
mechanism is also often referred to as ER/Golgi mechanism, because these compartments 
participate in the process. The proteins sequentially translocate through stacks of ER and 
Golgi in small membrane-enclosed vesicles in a process called cisternal progression. The 
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faith of majority of the proteins is being secreted when the vesicle fuses with plasma 
membrane, but this pathway is also responsible for delivering proteins that are intrinsic 
components of the secretory pathway (e. g. ER proteins), proteins that remain attached to 
the cellular membrane and those destined for lysosomal degradation. Additionally, 
secretory pathway machinery relies also on chaperones assisting with folding and post-
translational modifications. 
In eukaryotic cells, classical protein secretion immediately follows protein 
synthesis by ribosomes once the conventional signal sequence is detected. The 
translocation of a protein through the ER membranes can happen already at the beginning 
of translation (co-translational translocation), or after protein is fully synthesized (post-
translational translocation). 
 Signal sequence is a consensus 5-30 amino acid-long N-terminal sequence present 
on classically secreted pro-proteins. It contains a long stretch of hydrophobic amino 
acids, often forming an α-helix, which is thought to facilitate transfer of the protein 
through highly hydrophobic environment of ER membranes and plasma membrane. The 
signal sequence is recognized during early stages of translation by signal recognition 
particle, a ribonucleoprotein complex, which binds to it and halts the translation until the 
ribosome-RNA complex founds itself in the vicinity of Sec61 (SecYEG in yeast). Sec61 
is a channel forming a pore through the ER and cellular membrane, existing in a complex 
with three other proteins, called translocon. Once the ribosome docks at the ER 
membrane, the translation is continued and the polypeptide chain is pushed through the 
translocon, while the signal peptide is cleaved off by a signal peptidase, releasing the 
complete polypeptide chain into the ER lumen. 
Importantly, the secreted protein does not enter the ER lumen at random location. 
Complex molecular machinery participates in each stage of the process ensuring that the 
secretory vesicle is properly assembled. One critical component is the secretory vesicle’s 
coating with specific proteins called coat protein complexes (COP) COPI or COPII and 
Sar1p. In the anterograde (secretory) pathway COPII coats the secretory vesicle. The 
secretion process is balanced by retrograde (reversed) traffic, by vesicles labeled with 
COPI (Dancourt and Barlowe, 2010). COPII is a complex of two proteins that bind to 
Sar1p remaining at the ER membrane in the vicinity of the sorted cargo. The binding of 
COPII is associated with assembling of a protein complex of limited flexibility with the 
tendency to “pull out” the ER membrane, thus forming the cargo-loaded vesicle. 
The process of secretory protein trafficking via COPII-coated compartments is a 
subject of further specialized regulation dependent on their cargo. ER and Golgi are 
equipped with variety of molecules called sorting receptors that are capable of halting, 
rerouting or accelerating the secretory vesicle progression. Examples of such proteins are 
ERGIC-53 (Hauri et al, 2000), p24 (Strating et al, 2009), and Erv family proteins 
(Belden et al, 1996). Importantly, ER environment facilitates protein folding. There are 
also significant differences of the composition and local chemical environment (like pH) 
between secretory pathway compartments, providing a whole new level of regulation 
facilitating the classical secretion process. On top of that, different ER and Golgi 
compartments are occupied by proteins facilitating posttranslational modifications of 
newly synthesized protein so that it is mature and ready for secretion before it reaches the 
plasma membrane. 
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By consequent membrane blebbing/fusion events, the secretory vesicle containing 
the protein to be secreted progresses via ER and Golgi stacks towards the cellular 
membrane, avoiding exposure of the cargo to cytosol. After reaching the next 
compartment, the secretory vesicle is captured by tethering factors (t-soluble NSF 
attachment protein receptors (t-SNAREs) and Rab family GTPases), and fuses with the 
receptor compartment membrane (Bonifacino and Glick, 2004). 
The final step of classical secretion pathway occurs once the secretory vesicle fuses 
with plasma membrane releasing its cargo to extracellular space in a process called 
exocytosis.  
Immune cells, similarly to any other type of cell in the human body, are actively 
secreting multitude of proteins, including cytokines. Most cytokines follow the classical 
route of secretion (Stanley and Lacy, 2010). Their release can be either constitutive 
(when the protein is released immediately after synthesis) or regulated (when additional 
signal is required for release of the cytokine pre-packaged in secretory vesicles). 
Important classically secreted macrophage cytokines include TNF, IL-6 and IL-10. 
TNF is an important early response pro-inflammatory, multifunctional cytokine 
secreted by macrophages. TNF has an unusually long signal sequence that is cleaved off 
the protein just before its release. The precursor of the cytokine is transported through the 
classical route to accumulate in the recycling endosomes and its secretion signal is 
delivered by cleavage of the signal sequence by specialized enzyme TNF converting 
enzyme (TACE, ADAM17). The release is polarized since TACE is present primarily at 
the site of phagocytic cup (Stow et al, 2009), thus allowing for TNF release in local 
environment where it is desired. 
IL-6 has been shown to follow similar route through recycling endosomes, 
however its release is not limited to phagocytic cups (Manderson et al, 2007). It has 
been demonstrated that although IL-6 is co-expressed with TNF, it is subsequently sorted 
to distinct compartments, away from TNF (Stanley and Lacy, 2010). 
IL-10, a primary regulatory cytokine, is released subsequently to TNF and IL-6 and 
limits their pro-inflammatory effect. It is trafficked alongside the classical secretory route 
but after passing the trans-Golgi network it can be routed towards release in at least two 
distinct ways utilizing recycling endosomes (Stanley et al, 2012). 
 
2.2 Non-classical secretion mechanisms. 
 
Majority of extracellular proteins found in eukaryotic organisms do not contain N-
terminal signal sequence, and are consequently not secreted through the conventional 
pathway. Yet, both prokaryotic and eukaryotic organisms constantly secrete those 
proteins to the extracellular space, heavily increasing potential intercellular 
communication via other mechanisms. Collectively, they are called “non-classical” (or 
“unconventional”) secretory pathways and encompass a variety of bulk, vesicle-
dependent as well as vesicle-independent secretion of leaderless proteins. The current 
view suggests four distinct non-classical secretion routes (Rabouille et al, 2012), as 
depicted in Figure 3, although molecular mechanisms have not yet been fully elucidated. 
Crucially for immunity, also some important cytokines lack the signal peptide and 
their secretion must be achieved in non-classical way. A prominent example is the IL-1 
family and its most important member, IL-1β. IL-1β is a potent pro-inflammatory cyto- 
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Figure 3. Non-classical protein secretion mechanisms in humans. Type I secretion refers to 
delivery of protein to the surface in small vesicular structure, which gets anchored to the 
membrane via interaction with membrane lipids and forms a pore-like structure. Type II 
pathway is distinguished by using an ATP-binding cassette (ABC) transporters, which 
undergo conformational changes that mediate protein export. Type III describes vesicle-
mediated mechanisms, where proteins are delivered to the membrane onboard the 
membrane-enclosed compartments (lysosomes, autophagosomes, multivesicular bodies 
(MVB)) or bud in vesicle shedding process. Type IV classifies proteins bypassing the Golgi 
and being delivered to the surface via ER-dependent mechanisms. 
 
 
kine rapidly secreted by monocytes, macrophages, dendritic cells and B cells during 
activation of PRRs. It provides a boost signal for the adaptive immune response as well as 
activates innate immune cells to combat the pathogen more efficiently, but at the same 
time having disastrous effects on the organism when its secretion is not contained on 
time. Thus it is essential that the process of IL-1β secretion during inflammatory response 
is tightly regulated. 
The secretion of IL-1β has perplexed researchers ever since its discovery, and 
further experiments suggested several mechanisms of its secretion (Monteleone et al, 
2015). IL-1β is produced in a 31-32 kDa precursor form once the pathogen is detected by 
pathogen recognition receptors leading to activation of transcription factor NFκB. The 
precursor form of the protein, however, is not secreted, but accumulates in the cytosol. 
Instead, pro-IL-1β must be processed by activated caspase-1 into mature, 17 kDa form 
which is subsequently released. The signal for processing comes from inflammasome, 
which in turn provides a molecular scaffold for caspase-1 autoactivation. Importantly, 
caspase-1 is not only linked with IL-1β secretion, it has also been associated with 
secretion of many other unconventionally secreted proteins (Keller et al, 2008). Despite 
our relatively good understanding on how the maturation of IL-1β proceeds, its delivery 
to the surface and secretion remains controversial. 
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2.3 Bulk secretion of leaderless proteins. 
 
As the knowledge of vast numbers of leaderless proteins being exported from 
eukaryotic cells expanded, more molecular players regulating the release were identified.  
One proposed unconventional mechanism participating in protein secretion utilizes 
lysosomal vesicles. These were named secretory lysosomes and they seem to differ from 
degradative lysosomes in their composition or physicochemical properties (pH, presence 
of over 40 acid hydrolases). Their generation seems to overlap with endosomal pathway 
and they are likely involved in degradation of both exogenous (uptaken proteins, 
carbohydrates, nucleic acids and lipids) and endogenous (damaged organelles) material 
(Holt et al, 2006). Secretory lysosomes have been proposed to contribute to immune 
functions. They mediate processing and release of cytotoxic T lymphocyte granules, 
histamines, proteases and cytokines from mast cells and clotting agents from platelets 
(Holt et al, 2006). Also neutrophil granules are thought to sort via secretory lysosome-
like compartment (Sheshachalam et al, 2014). 
 
3. Extracellular vesicles 
 
The term “extracellular vesicles” (EVs) is now collectively used to describe a 
diverse group of membrane-enclosed nanosized extracellular entities, regardless of their 
size, density, formation mechanism, cargo load and delivery target. Existence of EVs 
have been first observed indirectly in 1946 (Chargaff and West, 1946) when it was 
noted that during blood clot formation the agents responsible for the conversion of 
prothrombin to thrombin could be depleted from the plasma by centrifugation at 31,000 g 
and concentrated into a pellet which retained the coagulating properties. Later advances 
of microscopic techniques allowed for direct observation of the EVs from human and 
mouse samples (Wolf 1967, Anderson 1969). 
During following years numerous other studies documented the presence of 
vesicle-like structures in various biological samples. In 1983 Pan and Johnstone 
demonstrated that in maturing sheep reticulocytes transferrin receptor is released from the 
cells on the surface of nanometer-sized vesicles (Pan and Johnstone, 1983). Two years 
later it was shown that EVs they had observed are not directly shed from the membrane, 
but instead formed inside distinct endosomal compartments called “multivesicular 
bodies” (MVB) (Pan et al, 1985). The term “exosome”, which until recently has been 
used most frequently to describe EVs, was first introduced by Vidal in 1989 (Vidal et al, 
1989). 
EVs have been shown to participate in intercellular trafficking and carry a diverse 
cargo. Although most studies focused on protein analysis, numerous studies demonstrated 
the presence of bioactive lipids (Subra et al 2007), nucleic acids (Valadi et al, 2007) and 
small molecules (Ha et al, 2016) in the EVs isolated from eukaryotic cells. EVs are 
secreted constitutively from mammalian cells, and their release is regulated by 
spatiotemporal conditions. 
EVs represent an important way of distant intercellular communication. Their 
cargo is protected from changes of environment by the lipid membrane, hence 
maintaining its functionality. The EV membrane is also well suited for fusion with 
recipient cell. Additional membrane-associated molecules and receptors may facilitate the 
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EV targeting. EVs express broad range of molecules on their surface, what can 
additionally target vesicles for specific receptor-mediated uptake. Due to their small size, 
EVs have also been shown to be taken up by phagocytosis (Feng et al, 2010). 
In an attempt to classify EV-mediated communication, Ratajczak and colleagues 
proposed distinguishing of three categories: a) inducing receptor-mediated signaling by 
surface-exposed ligands; b) surface receptor transfer, and c) delivery of RNA, proteins 
and lipids by fusion with recipient cell’s membrane or endocytic uptake (Ratajczak et al, 
2006). 
 
3.1 Classification of extracellular vesicles. 
 
As the EV research field started attracting broad attention, many researchers 
postulated classification of the membrane entities secreted by mammalian cells. 
Subsequent studies on EVs isolated from different cells suggested using distinct names to 
underline the origin of studied vesicles (dexosomes (Le Pecq, 2005), tolerosomes 
(Karlsson et al, 2001), oncosomes (Al-Nedawi et al, 2008) and prostasomes (Stegmayr 
and Ronquist, 1982)), size classification, flotation density (exosomes equilibrate at ca 
1.13-1.19 g/mL (Hugel et al, 2005)), but as later detailed analysis demonstrated, the clear 
separation of the populations of EVs is not possible (Witwer et al, 2013). In 2011 the 
International Society of Extracellular Vesicles was established and provided the scientific 
community with recommendation to use the term “extracellular vesicles” as an umbrella 
term for all kinds of secreted membrane entities (György et al, 2011). In terms of 
molecular mechanisms of generation and release, however, several types of EVs are still 
distinguished. 
Conventional classification system of EVs discriminates among 3 main groups (see 
Table 1). Smallest vesicles, exosomes, are considered to be 40-120 nm (some sources 
propose 30-100 nm) vesicles that are released from MVB lumen. Bigger particles 
(microvesicles or microparticles) are up to 1 μm in size and are thought to be directly 
shed from the plasma membrane. A third group has been associated with apoptosis of 
cells, which results in release of heterogeneous fragments of cells containing chromatin, 
called apoptotic bodies. This classification was supported by determination of differences 
in RNA profiles in the discussed populations (Crescitelli et al. 2013). 
The above classification of EVs became ambivalent and the boundaries between 
the groups increasingly blurred during the recent exponential increase in the number 
studies of different EV populations. Markers initially thought to be associated with only 
one type of vesicles and proposed to be used as markers were often identified in other 
populations too. Additionally, also other mechanisms have recently been proposed to 
participate in EVs release (e.g. secretory lysosome release, discussed above). Therefore 
current tendency is to use collective term “extracellular vesicles”. Former classifications 
are still, however, widely used. 
Recently, Kowal and collaborators suggested that classification based on 
sedimentation speeds lacks accuracy (Kowal et al, 2016) and recommended additional 
separation of ultracentrifugation-resulting pellet on iodixanol gradients, as well as using 
novel molecular markers which were proposed to be more specific in different 
populations. Future studies will certainly improve our understanding of differences 
among EVs and their secretion mechanisms. 
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Vesicle class Size range Originating 
from organelles 
Molecular 
markers 
Cargo 
exosomes 40-120 nm endolysosomal 
pathway, MVB 
tetraspanins, 
ESCRT 
components, 
flotillin 
mRNA, 
miRNA, 
proteins 
(cytoplasmic 
proteins, 
receptors, 
MHC) 
microvesicles >100 nm plasma 
membrane 
integrins, 
selectins, CD40L 
mRNA, 
miRNA, 
proteins 
(cytoplasmic 
proteins, 
receptors) 
apoptotic 
bodies 
>1000 nm plasma 
membrane, 
other 
intracellular 
compartments? 
phosphatidylserine nuclear 
fractions and 
organelles 
 
Table 1. Classification of EVs (Andaloussi et al, 2013). 
 
 
3.1.1 Exosomes 
 
Exosomes are very small (40-120 nm) and accumulate by inward budding in 
MVBs which are type of endosomes. They are enriched in proteins of cytosolic and 
membrane compartments, as well as endocytosed components. Consequently, classical 
markers of exosomes used in majority of studies are endocytic components TSG101 and 
Alix, which belong to broader group of endosomal sorting complexes required for 
transport (ESCRT) (Théry et al, 2002). On top of that, several other groups of proteins 
seem to be enriched in exosomes. Tetraspanins (CD9, CD81, CD63) are suggested to 
facilitate cargo sorting by forming tetraspanin-enriched microdomains. CD81 was 
directly demonstrated to modify exosomal cargo (Perez-Hernandez et al, 2013). 
Integrins and heat shock proteins have also been abundantly identified in exosomes. 
Interestingly, due to their regulated biogenesis and endosomal origin, exosomal 
membrane differs in composition form plasma membrane (Blanchard et al, 2002). 
Intracellular transport of MVBs containing exosomes and their composition has 
been linked with Rab proteins. Rab proteins belong to the Ras superfamily of monomeric 
G proteins and are associated with the intracellular membrane compartment. Rab proteins 
differentially regulate membrane fusion and fission events and have been suggested to 
tightly regulate endosomal transport along with actin (Jordens et al, 2005). Several Rab 
proteins have been shown to play roles in the formation of exosomes (Rab11, Rab27A, 
16 
 
Rab27B, Rab35 and others (reviewed in Urbanelli et al, 2013)), but the exact roles these 
proteins play in biogenesis of exoxomes remain to be determined (Ung et al, 2014). 
The final step of exosome release requires the fusion of MVB with the plasma 
membrane and release of intraluminal vesicles. Since this process requires membrane 
fusion/fission events, it has been suggested that it might be regulated by SNAREs. Indeed 
several SNAREs have been shown to be facilitating exosome secretion (reviewed in 
Urbanelli et al, 2013). 
Besides membrane components and proteins involved in exosome generation, 
exosomes contain abundance of biomolecules. Their cargo is not limited to proteins, they 
also carry DNA, RNA and bioactive lipids. Recent research suggests that also the non-
protein cargo differs from parent cell content and is subject to selective regulation 
(Huang et al, 2013). 
 
3.1.2 Microvesicles 
 
In contrast to exosomes, microvesicles consist of heterogenous populations of 
larger membranous structures. Classically microvesicles fall in the 100-1000 nm size 
range, although larger vesicles have been observed in analyzed samples. Microvesicles 
arise by plasma membrane budding, incorporating portions of local cytosol. Their release 
has been shown to be triggered by shear stress (Holme et al, 1997), as well as chemical 
and biological activation. Later studies showed that microvesicles arise in processes 
distinct from exosome generation and possess different characteristics, such as protein 
marker composition and preferential annexin V binding to surface phosphatidylserine on 
microvesicles (Heijnen et al, 1999). 
Microvesicle shedding is a way to dispose of accumulated proteins rapidly by 
membrane blebbing. MacKenzie and colleagues demonstrated that THP-1 macrophages 
secrete microvesicles within minutes from ATP stimulation and that these vesicles 
contain mature IL-1β. The event is associated with phosphatidylserine flip towards outer 
membrane (MacKenzie et al, 2001). 
It has been shown that microvesicle shedding from the cell surface is associated 
with dynamic changes in intracellular calcium levels, which seem to modulate activity of 
cytoskeleton-degrading proteins (Miyoshi et al, 1996). Numerous other studies 
demonstrated that calcium levels induce strong surface shedding responses and several 
signaling pathways have been suggested to regulate microvesicle production, including 
protein kinase C (PKC) and mitogen-activated protein (MAP) kinases (Pilzer et al, 
2005). 
Microvesicles, similarly to exosomes, have been associated with intercellular 
protein and RNA transfer and their roles in cancer metastasis, progression, inflammation, 
blood clotting and other physiological processes have been described (reviewed in 
Muralidharan-Chari et al, 2010). Not much is known about their cellular targets and 
uptake mechanisms. 
Membrane-shed vesicles incorporate also endosome-derived molecules, along with 
MHC, integrins and vesicle-associated proteins. Thus their composition is by large 
similar to exosomes, although detailed studies on the cargo transported by microvesicles 
and exosomes are ongoing and will shed new light on the different roles of these 
seemingly different classes of EVs (Kowal et al, 2016). 
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3.1.3 Other types of EVs 
 
Several other physiological processes have been involved in EVs generation. 
Apoptotic bodies are formed in the process of programmed cell death, where cells 
undergo chromatin condensation and fragmentation associated with cell shrinkage and 
membrane blebbing. These membrane blebs are normally larger than microvesicles, often 
exceeding 1 μm in diameter and contain random portions of cytoplasm, chromatin as well 
as tightly packed cellular organelles (Elmore, 2007). 
Apoptotic bodies express distinct markers on their surface, what allows them to be 
efficiently cleared by macrophages without triggering inflammatory response (Savill and 
Fadok, 2000). 
Another important physiological process involved in EVs generation is secretory 
autophagy. In classical view, autophagy is a process of regulated clearing of intracellular 
material and recycling building blocks. This is achieved when a portion of cytoplasm 
containing proteins, nucleic acids or whole organelles is isolated from intracellular milieu 
by enclosing in endosomal membrane, what leads to formation of intracellular vesicle 
called autophagosome. This compartment subsequently fuses with lysosome and leads to 
degradation of its contents. Autophagy is active on basal level in each living cell and its 
turnover is increased in stress conditions, especially starvation. 
In some cases, autophagosomes do not fuse with lysosomes for degradation, but are 
directed to plasma membrane for expulsion (Ponpuak et al, 2015). The mechanism of 
this process is not well-established, although some studies demonstrated that intracellular 
vesicle sorting can progress via MVBs and that these vesicles are labeled with classical 
autophagy-related protein LC3-II (Griffiths et al, 2012). 
Interestingly, secretory autophagy has also been linked with immunity, where, in 
contrast to degradative autophagy which is involved in intracellular microbe degradation, 
it has been suggested to contribute to pathogen spreading. Gerstenmaier and colleagues 
showed that autophagic pathway components are essential for non-lytic transmission of 
Mycobacterium tuberculosis from infected yeast cells. Multiple autophagy proteins 
(Atg1, LC3, Atg5, Atg7) are recruited to “ejectosomes”, structures that facilitate 
bacterium exit from infected cell (Gerstenmaier et al, 2015). Similarly, the spread of 
coxsackievirus B has been shown to be facilitated by EVs displaying autophagic markers 
(Robinson et al, 2014). 
 
3.2 Experimental techniques of EV isolation. 
 
Due to the extremely small size of EVs their isolation methods require dedicated 
techniques and special laboratory equipment. Most protocols applied in EVs studies rely 
on high-speed centrifugation, however, several other methods based on chemical 
properties and taking advantage of additional procedures have been developed. 
 
3.2.1 Ultracentrifugation methods. 
 
In most cases EVs can be pelleted by centrifugation at high speeds. Classically 
adopted approach relies on isolation of EVs from pre-clarified biological fluids and cell 
culture media by ultracentrifugation at 100,000-120,000 g for at least 1 h (Théry et al, 
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2006, Kalra et al, 2016). This method provides reliable, quick and robust means of EVs 
isolation with high yield. It has several disadvantages: does not allow for full separation 
of vesicles of different classes and it may be unsuitable for highly-viscous fluids. 
Additionally, ultracentrifugation might alter the morphology of isolated vesicles what 
might cause problems in further identification and analysis. 
For studies on exosomal pools often differential centrifugation methods are applied 
to eliminate larger contaminating vesicles. They involve sequential centrifugations of 
supernatants at increasing speeds. Typically, centrifugation of media at 500-2000 g is 
used to deplete the sample from intact cells, followed by a 3000-10,000 g centrifugation 
to sediment smaller cellular debris. Differential centrifugation can also be used if aiming 
at isolation of bigger vesicles, for example apoptotic bodies have been suggested to 
precipitate at 10,000-16,000 g (Lázaro-Ibáñez et al, 2014). 
Frequently used modifications of the ultracentrifugation method utilize density 
gradients. EVs of different classes or originating from multiple sources are presumed to 
have differing buoyant densities. Gradients frequently used in EVs isolations are prepared 
from sucrose (sometimes in D2O) or iodixanol. Gradient separation techniques are 
efficient in enriching EVs populations, and are currently best available methods to obtain 
highly pure EVs populations (Kalra et al, 2013). However, gradient methods are often 
associated with the need of higher sample quantity and more tedious sample handling, 
what can result in low reproducibility (Kalra et al, 2016). 
 
3.2.2 Other methods. 
 
Several other methods have also been developed as an alternative for high-speed 
centrifugation. Affinity-based methods involve the use of magnetic beads or 
fluorescence-activated cell sorting (FACS) beads, coated with antibodies targeting 
surface proteins on EVs populations. Beads have been coated with antibodies against 
proteins that are often accepted markers of EVs, including Alix, CD63, CD9 and 
EPCAM. Usage of such immunoaffinity methods is often linked with difficulties 
associated with specificity and selectivity of antibodies used. Non-specific protein 
binding has also been identified as a major problem (Kalra et al, 2016). 
One of the latest developed modifications of affinity-based methods relies on 
capture of EVs that flow over antibody-coated surface of a “lab-on-chip”, similarly to 
currently performed standard blood testing microfluidic devices. The EVs bind to the 
surface during sample flow, thus being separated from the liquid fraction and 
contaminants. Ashcroft and colleagues demonstrated such system using CD41-coated 
plate, subsequently demonstrating its functionality by measuring captured plasma EVs 
with atomic force microscopy (Ashcroft et al, 2012). 
Another recently developed method for EVs isolation utilizes filtration. 
Concentration of EVs on filter membranes is however linked to binding of EVs to the 
membrane material and subsequent difficulties in their recovery. To counteract this 
phenomenon, new low-protein-binding membranes were developed as an improvement 
(Merchant et al, 2010). Although quick and easy, isolation of EVs with filtration method 
does not lead to pure vesicular material, but can be used as a preliminary step before 
ultracentrifugation-based pelleting (Momen-Heravi et al, 2013). 
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EVs have also been reported to be efficiently enriched from human plasma by size 
exclusion chromatography on sepharose CL-2B, a cross-linked agarose gel beads. The 
study of Böing and colleagues suggested that this method efficiently separated pool of 
EVs from common plasma contaminants high density cholesterol and free plasma 
proteins resulting in 70-fold enrichment of vesicular protein with 45-60 % yield (Böing et 
al, 2014). 
 
4. Extracellular vesicles in immunity. 
 
In the context of immunity, EVs have attracted attention relatively recently, when it 
was realized that human immune cells secrete EVs that regulate immune responses. Since 
then the field of research of immunological context of EVs has been expanding 
dynamically (Kim et al, 2013). Current research continues to unravel novel roles that 
EVs play in the human immune system. 
 
4.1 Roles of EVs in signaling in innate and adaptive immunity. 
 
The first study that started the revolution in our understanding of the roles of EVs 
in immunity was the work by Raposo and colleagues, who isolated and characterized the 
EVs from B cells (Raposo et al, 1996). They showed that B cells incubated with M. 
leprae protein HSP65 secrete exosomal MHC class II in the peptide-bound conformation 
on their surface, what provides a novel route for antigen presentation and activation of 
adaptive immune responses. Antigen-presenting MHC class II molecules originated from 
endosomal compartment and it was presumed that they were loaded with peptide before 
ending up in the MVB on the surface of vesicles. Indeed, incubation of T cells with the 
peptide-loaded exosomes induced T cell activation. 
Further studies on EVs secreted by B cells shed more light on the process of their 
generation and their roles in immunity (reviewed in McLellan, 2009). It was shown that 
EV production in B cells is increased during their cross-talk with T lymphocytes. In 
particular, EV release is dependent on ligation of CD40 on the B cell surface by CD40L 
on T cell surface and parallel IL-4 release – the same signals that trigger the B cell 
maturation and antibody class switching. Interestingly, one study showed that B cell–
derived EVs contain antibodies of IgM and IgD classes, but upon B cell activation and 
class switching, the newly synthesized antibodies are secreted in soluble form 
(Saunderson et al, 2008). Finally, B cell-derived EVs may also serve as antigen delivery 
to DCs, which are capable of exosome uptake. 
Considerable research efforts have been put into investigation of DC-derived EVs. 
Zitvogel and colleagues showed that these expressed functional MHC complexes along 
with co-stimulatory molecules and were capable of presenting tumor-derived peptides to 
naïve T cells and contributed to eradication of tumor in mice (Zitvogel, 1998). Further 
studies showed that secretion of EVs by DC is also modulated by T cells. Similarly to B 
cell-derived EVs, vesicles from DCs proved to be capable of modulating adaptive 
immune responses, however several studies demonstrated that DC-derived EV-mediated 
T cell activation cannot reach full extent without participation of DCs themselves 
(Vincent-Schneider et al, 2002). This would suggest that EVs may serve as intermediate 
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conveyors of antigen presenting capacity to non-professional antigen-presenting cells 
(Segura et al, 2005). 
EVs are also secreted from macrophages. As these cells are mainly involved in 
active phagocytosis of pathogens, it is expected that during infections the EVs they 
secrete may serve purposes of antigen processing and delivery for presentation. Indeed, 
many studies demonstrated that macrophages infected with both extracellular and 
intracellular pathogens secrete MHC-antigen complex-bearing EVs. Infection of 
macrophages with M. tuberculosis leads to release of EVs containing bacterium-derived 
virulence factor lipoarabinomannan (Singh et al, 2012). Similar results of incorporation 
of pathogen-derived molecules into macrophage EVs were shown for M. avium 
(Bhatnagar and Schorey, 2007), Leishmania spp. (Hassani and Olivier, 2013) and S. 
typhimurium (Bhatnagar et al, 2007). This capability of transfer of microbial 
components is not restricted to proteins, as also functional mRNA and miRNA transfer 
was observed (Singh et al, 2015). 
EVs have been shown to be released by other immune cells and have been linked 
with modulation of their activation. This is true for natural killer (NK) cells, which 
secrete EVs that may contribute to their cytotoxicity; mast cells, that secrete EVs 
(independently of IgE cross-ligation) containing immunomodulatory MHC II, LFA-1 and 
ICAM-1 and capable of activation of adaptive responses; and T cells, whose EVs 
secretion profile changes upon cell activation (reviewed in Yáñez-Mó et al, 2015). 
 
4.2 EVs in clinical research. 
 
Versatile roles of EVs in immunity have lead researchers to increased awareness of 
their potential use in the clinics. Important research focuses on linking the basic 
discovery-based analysis of EVs with their diagnosic and therapeutical potential. 
EVs have been shown to be secreted from cancer cells and to play important roles 
in their biological functions. EVs are enriched in proteins essential for facilitating tumor 
establishment. Proteins like matrix metalloproteinases MMP2 and MMP9, whose role is 
the decomposition of collagen and establishing basement membrane, are present on 
tumor-derived EVs; growth factors EGF and VEGF, essential for vascularization, along 
with the crucial receptor mutants (EGFRvIII) that can be incorporated into target cell 
leading to adoption of tumoral phenotype (Al-Nedawi et al, 2008). 
EVs have been shown to mediate horizontal gene transfer in tumor cells, carrying 
RNA and DNA that modulates recipient cells expression profiles (Baj-Krzyworzeka et 
al, 2006). One profound example is shuttling of oncogene c-Myc, which was shown to be 
transferred as a retrotransposon to target cells (Balaj et al, 2011). 
Major efforts have been put into analysis of the EVs in the context of biomarker 
discovery for early cancer diagnosis, which dramatically improves prognosis of a cancer 
patient. EVs serve as excellent study material, as they can be easily isolated in reasonable 
quantities from body fluids with minimal invasiveness. Micro-RNAs (miRNA) carried by 
EVs are currently under heavy investigation and several studies showed selective 
enrichment of tumor-associated miRNA in the tumor EVs. It was proposed for example, 
that EV-related miR-141 can serve as a prostate cancer biomarker, as its presence was 
detected on the EVs of cancer patients but not on healthy controls (reviewed in Katsuda 
et al, 2014). 
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Also protein profiles of EVs from cancer patients give hints for biomarker 
discovery. EpCAM, CD24, caveolin-1, δ-catenin, survivin has all been found to correlate 
with the presence of certain tumors (reviewed in Katsuda et al, 2014). 
EVs are potential candidates for vaccines as they are capable of activation of T cell 
responses. Recent studies suggested using microbial EVs as vaccine components. One 
example is using the meningococcal outer membrane vesicles as a component of a 
vaccine against serogroup B meningococcal diseases in children (Carter, 2013). 
The roles of EVs in regenerative medicine have also been implicated, for example 
human liver stem-cell-derived EVs were found to improve the hepatic regeneration 
following partial hepatectomy of rats (Herrera et al, 2010). 
Efforts are put to utilize modified or artificially-generated EVs as vehicles for 
targeted drug delivery. Such approach allows for limiting the problems of undesired 
immunogenicity and toxicity that is often associated with existing drug therapies. Careful 
selection of EV production methods and their chemical modification can also improve 
potential selectivity for target (reviewed in Lener et al, 2015). 
 
4.3 EVs in viral infections. 
 
Studying EVs in the context of viral infections is not a trivial task, as EVs and 
virions overlap with most physical properties (size, density) and require elaborate and 
reliable methods of purification and results validation. Additional difficulty in dissecting 
EVs from viruses stems from the fact that many viruses share the same molecular 
machinery to enter, move around and exit the cells, with intracellular vesicular sorting. 
ESCRT pathway has been shown to be involved in budding of a remarkable variety of 
viruses, including HIV, human T cell leukemia virus, Ebola virus, herpes simplex virus 
(reviewed in Votteler and Sundquist, 2013). Nevertheless, research of EVs released 
during viral infections has attracted attention as vesicles might serve as envelopes for 
virus dissemination, shielding them from recognition by innate immune system and 
allowing non-enveloped viruses to acquire additional protection for their cargo. This 
phenomenon was named “Trojan exosome hypothesis” (Gould et al, 2003). Several 
studies confirm this theory. The study by Ramakrishnaiah et al. provided evidence that 
EVs secreted by hepatitis C virus (HCV) are able to transfer productive infection to non-
infected cells (Ramakrishnaiah et al, 2013). Similar results were obtained by Feng and 
colleagues in the case of related non-enveloped picornavirus (Feng et al, 2013). 
EVs from virus-infected cells have been proposed to promote virus spread by 
transferring receptors critical for the virion uptake to target cells. Mack and collaborators 
showed that HIV-1-infected Chinese hamster ovary (CHO) cells release EVs that transfer 
chemokine receptor CCR5 to monocytes which normally do not express it, rendering the 
monocytes susceptible to HIV-1 infection (Mack et al, 2000). Yet another mechanism of 
facilitating viral infection was proposed by Dukers et al., who determined that EV-
associated Epstein-Barr virus-derived protein LMP1 was responsible for inhibiting T cell 
responses and inducing T cell anergy (Dukers et al, 2000). 
Concurrently to these studies, protective roles for EVs in viral infections have also 
been suggested. One proposed mechanism involves transfer of antiviral proteins that 
protect the recipient cells from infection. Such proposal has been made by Li and co-
workers, who noticed that incubation of hepatocytes with EVs generated by IFN-α-
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stimulated liver nonparenchymal cells (including macrophage-like Kupffer cells) protects 
them from hepatitis B virus (HBV) infection due to development of “antiviral state” (Li 
et al, 2013), although the authors have not dissected the vesicular component responsible 
for this protection. 
EVs secreted by tracheobronchial epithelial cells have been shown to be enriched 
with mucins associated with α-2,6-linked sialic acid, which is known to bind to influenza 
hemagglutinin. Consequently, these EVs provide means for virus neutralization (Kesimer 
et al, 2009). 
 
5. Proteomics. 
 
The term “proteome” refers to a whole set of proteins present in a given cell at 
particular time. Proteome is subject to constant dynamic changes, regulated by synthesis 
of new proteins (related to gene expression), degradation of no longer needed proteins, 
chemical and enzymatic modifications of existing proteins, as well as exchange of 
proteins with the neighborhood (secretion and uptake). Analysis of the protein 
composition of a cell, organelle or conditioned medium can provide valuable information 
about the the cell dynamicsand related activity of metabolic processes. 
Proteomics is a set of analytical techniques for analysis of proteins in biological 
samples. Modern proteomic techniques combined with appropriate sample handling allow 
for identification of proteoforms (proteins and their biologically modified variants) from 
limited material of biologically complex sample. Mass spectrometry (MS) lies in the core 
of modern proteomic research. This analytical method allows for very accurate 
determination of a mass-to-charge (m/z) ratios of ionized chemical entities. 
The principles of a basic MS-based proteomic experiment are shown in Figure 4. 
More advanced proteomic techniques combine the basic setup presented in  
Figure 4 with different, more dedicated modifications allowing for obtaining in-depth 
information on protein structure in addition to identification. Proteomics have been used 
in many applications including studying protein composition changes, post-translational 
modifications, targeted proteomic analysis (where the instrument is set to analyze a 
selection of proteins of interest), protein-protein interactions. Many established 
approaches have now allowed the researchers to answer increasingly complex biological 
questions (Bensimon et al, 2012).  
Quantitative proteomics allows for simultaneously obtaining the absolute or 
relative quantification of protein amounts along with their identities. This proves 
particularly useful in studying e.g. the proteome response to stimuli in vitro or how a 
disease influences the proteomic composition of certain cells from a patient as compared 
with healthy controls. Various approaches for quantitative proteomics have been 
established, and they can be generally classified into two broad groups: label-free and 
label-based approaches.  
Label-free methods do not involve additional sample treatment and the 
quantification is derived from spectral counts or intensities of a recorded signal. Label-
based approaches utilize chemical modification (labeling) of analyzed proteins that can be 
exploited for quantification purposes during MS-based analysis. Multiple labeling 
techniques have been developed, including stable isotope labeling by amino acids in cell 
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Figure 4. Mass-spectrometry-based identification proteomics flowchart. In classical (bottom-
up) proteomics, the analyte is usually a mixture of pre-fractionated peptides resulting from 
enzymatic digestion of proteins. Peptides are separated by liquid chromatography (LC) and 
ionized using soft ionization techniques (electrospray). Ionized peptides are analyzed by 
tandem MS (MS/MS), where measurement of m/z of intact peptides is followed by 
fragmentation of the peptide and measurement of m/z ratios. The sequence of the fragmented 
peptides and their parent proteins are identified in silico from lists of m/z peaks obtained in 
the experiment. 
 
 
culture (SILAC) and isobaric tag for relative and absolute quantitation (iTRAQ). 
 SILAC (Ong et al, 2002) technique allows for metabolic labeling, i.e. introduction 
of heavy isotope-labeled amino acids into proteins during the process of their synthesis 
(in the culture). During MS analysis, distinguishing between heavy and light peptides lies 
at the base of relative quantification.  
Alternatively, isobaric protein labels may be introduced to peptides resulting from 
the digestion of proteins from differentially treated cells (Ross et al, 2004). In iTRAQ, N-
terminal amino groups of digested peptides are covalently linked to isobaric labels (4-
plex or 8-plex labelling utilizing 4 or 8 different isobaric labels, respectively) and 
quantification is achieved at the fragmentation level (MS/MS scan). Different labels are 
used to label different biological samples. iTRAQ-based protein quantification scheme is 
shown in Figure 5. 
 
5.1 Proteomics in EVs research. 
 
Proteomics have been widely used in EVs research to investigate the protein cargo 
the EVs carry. Combining high throughput proteomics with bioinformatics and functional 
studies has been a common approach for deriving biological roles that the vesicles play. It 
also allowed for understanding biological differences between different EVs pools, as 
well as between EVs from various cells and body fluids, providing basis for functional 
analyses. Current proteomic research on EVs serves dual purpose: (1) for characterizing 
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Figure 5. Principles of iTRAQ. A. Proteins isolated from differently treated biological 
samples are digested and peptides are labeled with iTRAQ reagents (4-plex labeling) at their 
N termini. The samples are then pooled, pre-fractionated and analyzed by LC-MS/MS. Each 
fragmentation spectrum contains peaks corresponding to peptide fragments as well as 
fragmentation of iTRAQ labels. Each label after fragmentation appears as a peak of a 
different mass, and the peak intensity corresponds to abundance of the peptide in each 
sample. The integration of relative peak intensities over peptides from each identified protein 
allows for determination of relative protein abundance among analyzed samples. B. 
Chemical structure of the iTRAQ label. Each tag has identical overall mass, but upon 
fragmentation in the collision cell of a mass spectrometer, the resulting reporter ions appear 
as distinct peaks providing basis for quantitative analysis. 
 
 
EVs as prognostic and diagnostic biological markers and (2) putting the EVs proteome in 
the context of biological phenomena (Kreimer et al, 2015). 
Early proteomic analyses of different EV-like structures were performed already 
after crucial discoveries of EVs properties in immunology field were made. First 
proteomic analysis was carried out by Théry and co-workers in 1999, who analyzed the 
most abundant proteins enriched in EVs as compared to cytosolic fractions of DCs, 
identifying 7 proteins, including MHC class II (Théry et al 1999). During following 
years similar approaches were adopted in other studies, but the size of aglobal vesicular 
proteome that was defined was largely limited (Théry et al, 1999, van Niel et al, 2001). 
Subsequent improvements in proteomic techniques and growing interest in EVs 
resulted in identification of thousands of EV-associated proteins from various body fluids 
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and cell cultures (Choi et al, 2014). High-throughput proteomics has been applied to 
studies of EVs isolated from body fluids: urine, semen (Poliakov et al, 2009), plasma 
(Looze et al, 2009), saliva (Gonzalez-Begne et al, 2009, Xiao and Wong, 2012), and 
breast milk (Admyre et al, 2007). Urinary EVs analyses discovered that human urine 
contains abundant EVs secreted by renal epithelium, urine duct and bladder. These 
studies focused on modulation of EVs composition in diseases affecting urinary tract 
(bladder cancer (Smalley et al, 2008), renal cell carcinoma (Raimondo et al, 2013), 
diabetic nephropathy (Zubiri et al, 2014)) and lead to identification of potential 
biomarkers for the diseases. Interestingly, proteomic studies of urinary EVs proved that 
their composition might also be related to occurence of other diseases not affecting 
urinary tract (reviewed in Wang and Sun, 2014). 
Proteomic analyses have also been applied for purposes of characterization of EVs 
populations. These studies aimed at determining fundamental differences between EVs 
classes. Casey and others performed proteomic characterization of gradient-purified 
secretory lysosomes from human NK cell line (Casey et al, 2007), identifying 221 
proteins including proteins typical for granule compartment of NK cells (including 
granzyme and perforin). Turiák et al. investigated the protein composition of apoptotic 
bodies as compared to membrane-shed microvesicles in mouse primary thymocytes using 
differential centrifugation. The proteomic analysis of apoptotic bodies revealed 
significant differences in the proteome of two vesicle types, with only 47 % of commonly 
identified proteins (Turiák et al, 2011). Pallet and colleagues investigated the secretory 
autophagic vesicles with proteomic techniques (Pallet et al, 2013). They demonstrated 
that vesicles from human umbilical vein endothelial cells (HUVEC) in early starvation 
stages contain fragments of mitochondria and ER. They are enriched in proteins which 
are hallmarks of autophagy, but are devoid of nuclear proteins and DNA. Together, these 
studies provided evidence that EVs purification using current techniques is a challenging 
task and that various seemingly distinct EVs populations share similar proteomes. 
In order to better understand the protein composition of EVs studied in proteomic 
experiments, extensive bioinformatic analysis have proved to be valuable for providing 
insights into biogenesis, formation, assembly and trafficking of EVs cargo. Proteomic 
data have been a subject of network analyses, mapping protein-protein interactions, and 
suggestive for preferential and tightly regulated protein sorting in EVs. Systems biology 
network-based analyses on EV proteins also provided information about their biological 
functions (Choi et al, 2012, Choi et al, 2013). Consequently, putting analyzed EV 
protein composition into context of biological responses that triggered their release using 
bioinformatic tools provides knowledge about processes involved in EVs generation and 
secretion. 
Subsequently, several publicly available internet databases have been developed to 
gather the existing knowledge from proteomic studies on EVs and make it easily 
accessible to any user. Exocarta (www.exocarta.org, Mathivanan and Simpson, 2009) 
was a first attempt to collect protein and RNA data available on exosomes. Subsequent 
attempts emerged when proteomic data on other, often complex, EV pools, were 
published. This lead to development of Vesiclepedia (www.microvesicles.org, Kalra et 
al, 2012) and finally EVpedia (www.evpedia.info, Kim et al, 2013). These databases also 
provide valuable statistical data on frequencies with which the proteins were identified, 
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differences between EVs from different species, cell types and categories and are now 
broadly used for reference information in EV research.  
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Aims of the study. 
 
The general aim of my thesis was to investigate the release of EVs under different 
innate immune responses of human macrophages to common pathogens, PAMPs and 
DAMPs. For this purpose, high throughput proteomic approaches combined with 
bioinformatics and functional studies were utilized. 
 
Specific aims of the thesis were defined as follows: 
 
I) To apply iTRAQ-based identification and relative quantification combined with 
detailed bioinformatics for analysis of EVs release from β-glucan-activated 
macrophages; 
 
II) To investigate and proteomically characterize ATP-induced unconventional protein 
secretion and further define roles for calpains in ATP-mediated activation of 
macrophages and vesicle release; 
 
III) To apply proteomics and bioinformatics in studying the EVs released from 
influenza A–infected macrophages. 
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Materials and methods. 
 
1. Cell cultures. 
 
Human monocyte-derived macrophages were used for experiments carried out in 
this thesis. Certain experiments presented in study II were performed on murine bone 
marrow-derived macrophages and cell lines. 
 
1.1 Human monocyte-derived macrophage culture. 
 
Monocytes were isolated from leukocyte-rich buffy coats obtained from Finnish 
Red Cross Blood Service as described by Pirhonen et al, 1999. Peripheral blood 
mononuclear cells (PBMC) were isolated by gradient centrifugation using Ficoll-Paque 
PLUS (GE Healthcare) and selected on plastic cell culture plates. Attached and washed 
monocytes were grown and differentiated into macrophages for 5 or 6 days in 
Macrophage-SFM medium (Life Technologies) supplemented with 10 ng/mL granulocyte 
macrophage colony-stimulating factor (GM-CSF) and antibiotics in 37°C,  
5 % CO2. 
 
1.2 Murine bone marrow-derived macrophages. 
 
Murine bone marrow-derived macrophages were differentiated from C57BL/6 wild 
type (Scanbur) or P2X7 knock-out (Jackson Laboratory) mice bone marrow cells. The 
bone-marrow cells from femurs of sacrificed mice were washed with phosphate-buffered 
saline (PBS) and red blood cells were lysed using Red Blood Cell Lysis Buffer (Sigma). 
Remaining cells were washed and plated. The cells were grown for 7 days in 37°C, 5 % 
CO2, in the RPMI medium (Life Technologies, 80 %) combined with L929-conditioned 
DMEM medium (Life Technologies, 20 %), supplemented with  10 % FBS, 1 % 
glutamine, 1 % HEPES, 0.05 mM β-mercaptoethanol, 1 mM sodium pyruvate, non-
essential amino acids and antibiotics to differentiate into macrophages. For stimulations, 
the medium was removed, cells were washed with PBS twice and RPMI medium 
supplemented with L-glutamine and antibiotics was used. 
 
1.3 Cell lines. 
 
In study II some experiments were performed on THP-1, a human monocytic cell 
line from monocytic leukemia patient. Cells were obtained from ATCC (TIB-202) and 
differentiated to adopt macrophage-like phenotype in RPMI medium (Life Technologies) 
using 1 μg/mL LPS (Invivogen) and 1000 U/mL IFN-γ (ImmunoTools) for 48 h prior to 
experiments, as described by Humphreys and Dubyak (1998). 
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2. Stimuli and inhibitors used in experiments. 
 
Several experiments utilized pharmacological inhibitors and stimuli that were used 
as negative or positive controls. Table 2 summarizes the reagents used throughout the 
work. 
 
Stimuli Manufacturer Concentration Used in 
the study 
LPS (E. coli O111:B4) Sigma-Aldrich 100 ng/mL or 1 μg/mL II 
Nigericin Sigma-Aldrich 10 μM II 
Curdlan Dako 10 μg/mL I 
Heat-killed C. albicans Invivogen 107 cells/mL I 
Influenza A Udorn/72 
(H3N2) 
in-house 2.56 hemagglutination 
U/mL 
III 
ATP Sigma-Aldrich 3 mM II 
 
 
Inhibitors Molecular target Manufacturer Concentration Used in 
the study 
AZ10606120 P2X7 receptor Calbiochem 10 μM II 
BAPTA-AM Intracellular Ca2+ 
chelator 
Enzo Life 
Sciences 
10 μM II 
Ca-074 Me Cathepsin B Calbiochem 25-50 μM II 
Calpeptin Calpains Calbiochem 100 μM II 
MDL28170 Calpains Calbiochem 10-100 μM II 
PD150606 Calpains Calbiochem 100 μM II 
Z-YVAD-FMK Caspase-1 Calbiochem 25-50 μM II 
 
Table 2. List of stimuli and pharmacological inhibitors used in presented studies. 
 
 
3. Extracellular vesicles. 
 
3.1 Isolation of EVs. 
 
For EVs isolation conditioned medium was cleared from cells and large particular 
debris by 10 min centrifugation at 500 g and subsequent 3000 g for 30 min at 4°C. The 
supernatant was then concentrated on 100 kDa MWCO centrifugal filter units (Amicon), 
diluted with cold fresh PBS and EVs isolation followed immediately. 
The concentrated conditioned medium (250-1000 μL) was diluted with cold sterile-
filtered PBS and ultracentrifuged for 1 h at 100,000 g, 4°C using Sw 55 Ti rotor 
(Beckman-Coulter) in 5 mL polyallomer ultracentrifuge tubes (Beckman). The vesicle 
pellet was washed with fresh, cold PBS and ultracentrifuged again at the same conditions. 
Resulting vesicles were resuspended in Laemmli sample buffer for direct blotting analysis 
or proteomic analysis (study III). For iTRAQ experiments (study I), the pellet was 
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resuspended in sterile PBS and used for 2-D Clean-Up Kit (GE Healthcare) protein 
purification. For nanoparticle tracking analysis (NTA) vesicle pellet was resuspended in 
PBS. For EM vesicle pellet was fixed with 2 % paraformaldehyde, pH 7. 
Figure 6 presents the experimental flowchart of EVs isolation. 
 
 
 
Figure 6. Experimental flowchart of EVs isolation. 
 
 
3.2 Nanoparticle tracking analysis. 
Isolated EVs (studies I and II) were resuspended in PBS and analyzed using blue 
laser (405 nm) in LM14C instrument (NanoSite Technology) connected to CMOS camera 
(Hamamatsu Photonics K.K.). The resultant concentration and size distribution of 
vesicles were recorded using dedicated software and processed manually. Each 
experiment consisted of a biological duplicate and each biological replicate was analyzed 
three times, as described in the study I. 
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3.3 Electron microscopy. 
 
Isolated and washed EVs were resuspended in 2 % paraformaldehyde/PBS (pH 7), 
mounted on electron microscopy grids and observed with Jeol 1200 EX II or Jeol 1400 as 
described in studies I, II, III. The samples were mounted on the grids as described by 
Théry et al, 2006. 
Immunogold labeling (study I) with anti-pan14-3-3 (Santa Cruz Biotechnology, sc-
629) and anti-annexin A1 (Santa Cruz Biotechnology, sc-12740) was performed as 
described by Théry et al, 2006. Antibody-labeled proteins were visualized with 
secondary antibodies conjugated with 10 nm gold particles (courtesy of Electron 
Microscopy Unit, University of Helsinki). The labeled vesicles were mounted on grids 
and observed as described. 
 
4. Sample collection and analysis. 
 
4.1 Macrophage cell lysates. 
 
Cell medium was aspirated and cell monolayers were washed once with PBS. Cells 
were detached from plates using rubber cell scrapers into ice cold PBS. Cells were 
pelleted and washed once with fresh ice-cold PBS. After the washing cells were lysed in 
lysis buffer 6 (R&D Systems) or in-house-prepared NP-40-based lysis buffer, 
supplemented with protease and phosphatase inhibitor cocktails (Sigma). For Western 
blots, the loading was equilibrated according to protein concentration or silver stain 
intensity. 
 
4.2 Macrophage conditioned media. 
 
For total secretome analysis (study II), macrophages were stimulated in serum-free 
media with ATP for 15 min. The culture medium was collected and cleared from 
detached cells by centrifugation at 400 g for 7 min. The clarified medium was 
concentrated on 10 kDa MWCO centrifugal filter units (Amicon) for secretome analysis. 
For direct vesicle-enriched fraction analysis, conditioned cell medium was cleared 
from cells by 10 min centrifugation at 400 g and subsequently concentrated on 100 kDa 
MWCO centrifugal filter units (Amicon). For general EV marker immunoblots in total 
secretome, 10 kDa MWCO centrifugal filter units were used in some experiments. 
 
4.3 Immunoblotting. 
 
Cell lysates, concentrated media samples and isolated EVs were mixed with 
appropriate volumes of Laemmli sample buffer and separated on AnyKD 
MiniPROTEAN TGX gels (Bio-Rad). The separated proteins were subsequently 
transferred to PVDF membranes. The membranes were blocked with 5 % non-fat milk in 
Tris-buffered saline-Tween 20 (TBS-T) and incubated overnight with designated primary 
antibodies at 4 °C. On the following day the unbound antibodies were washed with TBS-
T and the membranes were incubated with appropriate HRP-conjugated secondary 
antibodies (Dako). The chemiluminescence detection using ECL-Plus (Pierce) followed 
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the extensive membrane washing. Antibodies and their vendors are specified in the 
respective articles (studies I-III). 
 
4.4 Enzyme-linked immunosorbent assay (ELISA). 
 
The concentration of IL-1β secreted into extracellular medium (study II) was 
measured with human IL-1β Eli-pair ELISA kit (Diaclone) or with human IL-1β Ready-
Set-Go! kit (eBioscience). 
 
4.5 Calpain activity assay 
 
Calpain activity measurement was performed as described in the study II. Briefly, 
calpain activity was measured with CalpainGLO Protease Assay (Promega) as described 
in the study II. Briefly, macrophages seeded on 96-well plate were incubated with calpain 
substrate (20 μM) for 30 min. Cells were subsequently stmulated with ATP (3 mM) for 
30 min, washed and lysed with 0.9 % Triton-X, and incubated with calpainGLO 
luciferase detection reagent for 15 min. The luminescence was recorded using Victor3 
plate reader (PerkinElmer). 
 
4.6 Cytotoxicity assay. 
 
Cell cytotoxicity (study II) was measured by detection of lactate dehydrogenase 
activity using Cytotoxicity Detection Kit Plus (Roche) according to manufacturer’s 
instructions. 
 
4.7 Real-time PCR. 
 
Expression of indicated genes (study II) was studied with quantitative real-time PCR 
using ABI Prism 7500 Fast System (Applied Biosystems) with dedicated reagents and 
primers. The relative quantification was performed using 18S rRNA as endogenous 
control to normalize cDNA loading variation and achieved with comparative Ct method. 
 
4.8 Calcium influx measurements. 
 
ATP-activated Ca2+ influx associated with P2X7 receptor activation was studied live 
cell fluorescence microscopy (study II) as described by Louhivuori et al (2010). Briefly, 
cells grown on coverslips were loaded with Fura-2 acetoxymethyl ester for 20 min, 
mounted in perfusion chamber and observed under microscope with alternating 340/380 
nm excitation using narrow band filters. Fluorescence emission was measured through a 
430 nm dichroic mirror and a 510 nm barrier filter with a Cohu CCD camera, recording 
one image set per second. 
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5. Proteomics. 
 
5.1 iTRAQ proteomics of curdlan-stimulated macrophages (study I). 
 
iTRAQ experiments were performed essentially according to manufacturer’s 
protocol (iTRAQ 4-plex kit, AB Sciex). For iTRAQ experiments EVs were isolated from 
100-120 mL conditioned media. The resulting washed pellet was resuspended in small 
volume of PBS and total protein precipitation was performed using 2D Clean-Up kit (GE 
Healthcare) according to manufacturer’s instructions. The resulting protein pellet was 
solubilized directly into iTRAQ dissolution buffer. Proteins were reduced, alkylated and 
in-solution digested overnight with trypsin (Promega). The peptides following the 
digestion were labeled with iTRAQ reagents (control using 114 label and curdlan using 
116 label), pooled and subjected to separation on strong cation exchange (SCX) 
polySULPHOETHYL A column using ÄKTA high-pressure liquid chromatography 
(HPLC) system. The SCX fractions containing labeled peptides were analyzed on an 
Ultimate 3000 nano-LC (Dionex) coupled with QSTAR Elite hybrid quadrupole time-of-
flight mass spectrometer (AB Sciex). Protein identification and relative quantification 
was done using Protein Pilot 4.0 software (AB Sciex) with Paragon search engine and 
reviewed SwissProt database (February 2012). The identification and quantification data 
was additionally manually curated to ensure stringent criteria of spectra quality (at least 
two unique peptides with good quality spectra per protein, reporter ion peaks of at least 
10 counts). 
 
5.2 Secretome analysis from ATP-stimulated macrophages (study II). 
 
The pre-cleared, concentrated conditioned media were loaded onto 12 % TGX mini 
gel (Bio-Rad) for protein separation. The gel was silver stained and protein lanes were cut 
into 12 pieces and treated separately. The proteins were reduced, alkylated and in-gel 
digested with trypsin. The peptides were eluted twice using 0.1 % trifluoroacetic acid 
(TFA)/50 % acetonitrile (ACN) and analysed with Ultimate 3000 nano-LC (Dionex) 
coupled with QSTAR Elite hybrid quadrupole time-of-flight mass spectrometer (AB 
Sciex). The protein identification was carried out with in-house Mascot search engine 
against SwissProt database. 
 
5.3 Proteomic analysis of EVs from influenza A-infected macrophages (study III). 
 
EVs were isolated from 50-80 mL of conditioned medium. Samples from control and 
IAV-infected cells were treated in parallel. The purified and washed EVs were solubilized 
in Laemmli sample buffer and the proteins were separated on Any-KD Mini-PROTEAN 
TGX gels (Bio-Rad) and visualized by silver staining. The protein lanes were divided into 
5-7 fractions and processed in parallel. The proteins were reduced, alkylated and in-gel 
digested overnight with trypsin (Promega). The peptides were eluted twice with ACN - 
0.1 % TFA, dried and stored until the analysis. For mass spectrometry, the peptides were 
solubilized in 0.1 % TFA and analyzed on Q Exactive Hybrid Quadrupole-Orbitrap mass 
spectrometer (Thermo Fisher). 
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Proteins were identified with Proteome Discoverer using Mascot search engine 
against SwissProt database (November 2015). 
 
5.4 Bioinformatic analysis. 
 
Proteomic data was analyzed for Gene ontology (GO) using WebGestalt 
(bioinfo.vanderbilt.edu/webgestalt; Zhang et al, 2005, I) and GoMiner 
(https://discover.nci.nih.gov/gominer/index.jsp; Zeeberg et al, 2003, II and III). GO 
enrichment analysis was performed with Biocarta 
(http://cgap.nci.nih.gov/Pathways/BioCarta_Pathways) and Database for Annotation, 
Visualization and Integrated Discovery (DAVID, https://david.ncifcrf.gov/summary.jsp; 
II). Pathway analysis was done by Kyoto Encyclopedia for Genes and Genomes (KEGG, 
http://www.genome.jp/kegg). Exocarta (www.exocarta.org; Mathivanan and Simpson, 
2009) and Vesiclepedia (www.microvesicles.org; Kalra et al, 2012) were used for 
verification of vesicular proteins. Ingenuity Pathway Analysis (IPA, Ingenuity Systems, 
Mountain View, CA, www.ingenuity.com) was used for identification of cellular 
pathways and networks (I, III). Signal peptide analysis was performed with SignalP 4.1 
(http://www.cbs.dtu.dk/services/SignalP; Petersen et al, 2011) web-based server (I, II, 
III). 
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Results. 
 
Macrophages are primary phagocytic cells responsible for direct sensing and 
elimination of pathogens. In the first phase of acute immune challenges, type I 
macrophages (M1) play key roles. M1 macrophages differentiate from circulating 
monocytic cells in the presence of PAMPs and DAMPs. In vitro, differentiation into M1 
can be achieved with granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-
CSF differentiated macrophages resemble alveolar macrophages (Akagawa et al, 2006), 
what provides a suitable model for studying early innate immune responses against 
inhaled pathogens like fungi and influenza virus. 
Macrophages are also important regulatory cells, secreting a range of cytokines and 
chemokines affecting and coordinating the immune responses. Apart from signaling 
molecules, macrophages constitutively and actively secrete multiple other proteins. 
Analysis of the macrophage secretome is important for identifying the novel roles that 
macrophages play in the context of immune challenges. In particular, EV-secretome has 
attracted considerable attention throughout recent years. Despite dynamic research on 
roles of EVs, the scientific community is still in need for in-depth proteome studies of 
macrophage-derived EVs and their roles in immunity. 
 
1. Analysis of total and EV-mediated protein secretion in response to microbial 
PAMPs, DAMPs and viral infection (I, II, III). 
 
In this work we have analyzed the EVs secretion in the context of human primary 
monocyte-derived macrophage responses to well-known activators of immune responses: 
curdlan (study I), ATP (study II) and influenza A virus (strain Udorn/72/H3N2, study III). 
Curdlan is a (1,3)-β-glucan, a fungal PAMP activating dectin-1 signaling. ATP was used 
as a DAMP present in the circulation upon tissue damage. 
Activation of macrophages with the different stimuli triggered robust EVs secretion 
as compared with constitutive secretion by non-stimulated cells. This was confirmed by 
several independent methods (silver staining, immunoblotting demonstrated increase 
protein content in the secreted vesicle fraction, and with NTA, (Figure 8)). The extent of 
vesiculation differed dramatically among the investigated stimuli. While stimulation of 
the cells with curdlan for 18h induced modest, 3-fold increase in EVs secretion, 
stimulation with IAV over 9 h increased the EVs secretion 27-fold and 15 min-long ATP 
activation by 100-200 times.  
 
1.1 Morphological analysis of secreted EVs with EM (I, II, III). 
 
To verify the presence and determine the morphology characteristics, isolated EVs 
were analyzed with transmission electron microscopy (EM). EM observation confirmed 
the presence of EVs in the ultracentrifugation pellets. The isolated vesicles had cup-
shaped morphology (Figure 9). 
Importantly, morphology of EVs from IAV-infected cells was clearly different from 
isolated influenza virus that was used for experiments of study III. Although viral 
particles overlapped in size with EVs, they did not adopt “collapsed” cup-shape morpho- 
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Figure 7. Summary of performed experiments. Purified EVs (studies I and III) or total 
secretome (study II) from stimulated macrophages were subjected to proteomic analysis 
using different approaches and identified proteins were further analyzed using bioinformatics 
tools and functional studies. 
 
 
logy, remaining uniform in size and round (Figure 9, images 6 and 7). Such structures 
were not observed in the EVs samples. 
The observed vesicles varied in size from approximately 40 nm to over 1 μm in 
diameter. Majority of vesicles observed in each study was smaller than 200 nm. The 
observed size distribution corroborated the results of NTA analysis in studies I and II (see 
study I, fig. 1 and study II, fig. 1). 
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Figure 8. EV-mediated protein secretion analysis. A. Silver stain and immunoblot analysis of 
vesicular integrin αX (ITGAX, a prominent marker of macrophage-derived vesicles) 
demonstrates increased EV-mediated protein secretion from macrophages stimulated with 
curdlan for 18 h (curd), ATP for 15 min and IAV for 9 h. B. NTA relative vesicle 
quantification from secreted media showing EVs fold increase (ctr = 1). 
 
 
2. Quatitative proteomics and bioinformatic analysis of EVs secreted upon curdlan 
stimulation (I). 
 
Proteomic analysis of EVs secretion upon curdlan stimulation identified total of 540 
secreted proteins and statistically significant quantifications were obtained for 145 of 
them (study I, supplementary table 1). 
80 % of the identified proteins were listed in Exocarta. SignalP predicted the 
presence of a signal peptide in 20 % of the identified proteins. GO classification of the 
identified proteins suggested that membrane-associated proteins are enriched in the EVs 
(study I, fig. 2). 
In the proteomic analysis we identified numerous proteins characteristically 
expressed in macrophages, including integrins, macrophage receptors and integral 
membrane proteins (study I, Table I and fig. 3). Interestingly, many proteins belonging to 
the family of MHC proteins, a protein complex essential for antigen presentation in 
antigen-presenting cells were also detected. We found incorporation of numerous 
macrophage receptors into EVs (M6PR, FCER1G, C5AR1, MSR1). 
The presence of these external surface receptors is indicative that surface membrane 
38 
 
 
 
Figure 9. Electron microscopy analysis of EVs from experiments performed in the presented 
studies. Images 1-6: control (left) or stimulus used in experiment (right) indicated. Each pair 
of micrographs represents an independent experiment. Image 7: EM observation of Influenza 
A virus used in experiments. EM was performed using Jeol 1200 Ex II (study I) and Jeol 
JEM-1400 (studies II and III) electron microscopes and electron micrographs were generated 
using CCD cameras. Notice different magnification of presented images. Respective scale 
bars are shown. IAV - EVs from IAV-stimulated macrophages. 
 
 
compartment at least partly constitutes the analyzed vesicle pool, suggesting membrane- 
shed vesicles. Importantly, the P2X7 receptor was also identified, and its presence in the 
EVs fraction was confirmed by immunoblotting (study I, fig. 5). 
Ingenuity Pathway Analysis (IPA) is a bioinformatic tool for analysis of biological 
contexts in the complex experimental data based on pathway and network assembly. In 
our dataset we identified 9 integrins (6 α-integrins and 3 β-integrins) associated with 
vesicles and IPA analysis suggested a link between the identified integrins and 
cytoskeletal components. Interestingly, many other cytoskeletal and cytoskeleton-
associated proteins in the pathway were also identified in our analysis. We showed the 
39 
 
presence of several of them (talin, actinin and associated integrin-linked kinase ILK) on 
the secreted EVs fraction (study I, fig. 4). The identified proteins may play important 
roles in targeting and delivery of the EV cargo to recipient cells. 
Macrophage-derived EVs result from membranous structures shared by different 
compartments inside the cell, as well as plasma membrane. Our data confirmed the 
presence of many proteins (study I, Table 1) that were previously suggested as membrane 
markers of macrophages (Becker et al, 2012). 
Importantly, the bioinformatic analysis linked the identified proteins with IL-1β. We 
decided to investigate whether IL-1β is secreted upon curdlan stimulation in association 
with EVs fraction. Immunoblotting analysis demonstrated that the mature 17 kDa form of 
IL-1β is present in soluble secretome fraction, and that the 31 kDa precursor was 
preferentially associated with vesicles (study I, fig. 5A). 
 
3. Proteomic and functional analysis of ATP-induced secretome of human 
macrophages (II). 
 
LC-MS/MS method was applied to analyze the total secretome of ATP-stimulated 
macrophages. Three biological replicates of total secretome reliably identified 268 
proteins from unstimulated cells and 405 from ATP-stimulated cells. 94 and 188 proteins 
were identified in at least two replicates, respectively. 169 of 188 proteins identified from 
ATP-stimulated secretome were also listed in Exocarta (study II, fig. 1).  
Gene ontology (GO) is framework for biological context analysis, using 
classification of given proteins and analyzing potential enrichment of determined classes 
(Ashburner et al, 2000). The GO analysis showed that the number of membrane proteins 
increases in the secretome upon ATP stimulation (study II, Supplementary table II). 
Having identified a significant number of proteins present in Exocarta, we studied 
the release of EVs associated with macrophage activation by ATP. We found that vesicle 
release is rapidly (within minutes) and robustly (more than 100-fold as compared with 
control cells) activated by ATP in human macrophages (study II, fig. 3C). We confirmed 
the increased presence of EVs in the secretome of ATP-stimulated macrophages by 
blotting the vesicular markers (talin-1, integrin αX, α/β-tubulin and galectin-3), EM 
(study II, fig. 1) and NTA analysis (study II, fig. 1 and 3). 
 
3.1 ATP triggers vesicle-mediated protein secretion in a calpain-dependent manner. 
 
Bioinformatic analysis of GO terms associated with the secretome of human 
macrophages activated with ATP suggested possible roles for calpains 1 and 2, a family 
of non-lysosomal proteases, in the ATP-mediated protein secretion (study II, fig. 2A). We 
showed that calpains are activated in ATP-stimulated human macrophages. Upon 30 min 
of ATP challenge we observed an increased calpain activity in both cytosolic and 
membrane fractions (study II, fig. 2B and C). The activation of calpains was P2X7-
dependent, as the calpain activation was clearly inhibited by AZ10606120, a 
pharmacological inhibitor of P2X7. Additionally, bone marrow-derived macrophages 
from P2X7 KO mice showed no calpain activation upon ATP stimulation (study II, fig. 
2D and E). 
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In order to study if calpain activity is essential for ATP-related EVs release, we used 
MDL28170, a specific inhibitor for calpains. We showed that inhibition of calpains with 
MDL28170 completely suppresses the EVs release, as demonstrated by several 
independent methods: silver staining of total EV protein, immunoblotting of EV markers 
talin-1, integrin αX, α/β-tubulin and galectin-3, and electron microscopy (study II, fig. 3). 
Similar results were observed when AZ10606120 was used to inhibit the P2X7 receptor. 
The significant inhibition of vesicle release raised a possibility that MDL28170 acts 
as an inhibitor of the ATP-mediated signaling upstream of Ca2+ influx, inhibiting P2X7 
receptor. To rule out this possibility, we studied immediate Ca2+ influx associated with 
P2X7 activation using dynamic live-cell fluorescent microscopy in perfusion chamber. 
Macrophages seeded on coverslips were perfused with medium containing ATP alone or 
ATP and MDL28170. The calcium influx was measured by fluorescence signal from 
Fura-2/AM. These measurements demonstrated that MDL28170 does not block P2X7 
receptor and does not inhibit calcium influx (study II, fig. 6D). Consequently, MDL28170 
did not inhibit the P2X7-mediated signaling. 
 
3.2 Calpain activity is essential for downstream P2X7 signaling, inflammasome 
activation, IL-1β secretion and cell death. 
 
ATP is a well-known activator of NLRP3 inflammasome, a molecular platform 
activating caspase-1 and consequent IL-1β secretion in macrophages (Mariathasan et al, 
2006). NLRP3 inflammasome activation has been shown to be regulated by cytosolic 
potassium concentration (Muñoz-Planillo et al, 2013). At the same time raising 
concentration of cytosolic Ca2+ modulates calpain activity. Loss of cytosolic K+ and 
concurrent raise of cytosolic Ca2+ is the exact outcome of ATP-mediated activation of 
P2X7. We were therefore interested if calpains play role also in NLRP3 inflammasome 
activation. 
The cells were primed with LPS to induce pro-IL-1β synthesis at times indicated in 
the study II and challenged with 3 mM ATP in the presence or absence of MDL28170. 
IL-1β production was measured from cell lysates and cell culture supernatants. ATP 
stimulation induced robust IL-1β secretion from LPS-primed macrophages, which was 
inhibited in a dose-dependent manner by MDL28170 (study II, fig. 4). To verify that the 
inhibition is not unspecific or associated with another mechanism, we used other calpain 
inhibitors (calpeptin and PD150606), observing similar effects (study II, fig. 4). 
Nigericin is a bacterial toxin derived from Streptomyces hygroscopicus and acts as a 
potent potassium ionophore independently of P2X7 (Perregaux and Gabel, 1994). We 
found that nigericin-induced IL-1β secretion is not inhibited in the presence of calpain 
inhibitor. Hence, calpain roles are specifically associated with P2X7 activation (study II, 
fig. 4D). 
It was important to verify the roles which calpains play upstream of IL-1β 
maturation, in inflammasome activation. Inflammasome activity can be directly measured 
by studying ASC oligomerization (Bryan et al, 2009) and caspase-1 cleavage, as well as 
secretion of inflammasome components (Martinon et al, 2006, Hornung et al, 2008). 
Macrophages were primed with LPS and stimulated with ATP in the presence or absence 
of MDL28170. Both abovementioned hallmarks of inflammasome activation were 
completely inhibited when cells were treated with MDL28170 (study II, fig. 6). This 
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indicates that calpain activity is essential for NLRP3 inflammasome activation and 
resulting IL-1β secretion in human macrophages. 
To investigate if the observed inflammasome activation and IL-1β secretion were not 
due to cell death, the extent of necrosis was studied by lactate dehydrogenase (LDH) 
release. As Fig. 5 in study II indicates, LDH release was completely blocked by 
pretreatment of macrophages with MDL28170. 
 
4. Analysis of EVs secretion by macrophages infected with IAV (III). 
 
The objective of study III was to perform proteomic analysis of EV-mediated protein 
secretion in human macrophages infected with IAV. In kinetic experiment we determined 
that protein secretion is activated from IAV-infected cells at 9 h post-infection, as total 
protein staining indicated. Immunoblot analysis demonstrated the presence of EV marker 
protein Alix in the secretome (study III, supplementary fig. 1). The pattern of Alix 
secretion was in agreement with total protein secretion increase, corresponding to gradual 
activation of EVs release. 
Total vesicular protein analysis by silver stain confirmed that IAV induced strong 
secretion of EVs. The presence of EVs was also confirmed by electron microscopy (study 
III, fig. 1). 
We performed LC-MS/MS analysis of EVs from influenza A-infected human 
macrophages. In two biological replicates we identified a total of 1448 and 2359 human 
proteins from EVs from control and IAV-stimulated sample, respectively, of which 1299 
poteins were common. 
SignalP analysis of EV proteins showed that 25 % (control) and 21 % (IAV) of 
identified proteins were predicted to be secreted via classical secretory pathway. 
We compared the identified proteins with Vesiclepedia. 7 % of control and 10 % of 
IAV EV proteins were not identified on EVs before. Significant fraction of those novel 
proteins also contained signal peptide (study III, fig. 1). 
Bioinformatic analysis using GO annotation confirmed strong association of 
identified proteins with extracellular vesicular exosome structures. Uniquely for EVs 
from IAV-infected cells, the analysis revealed that identified proteins may play roles in 
regulation of gene expression and translation (study III, fig. 2 and 3). Analysis using IPA 
was used to link the identified proteins to canonical pathways, indicating significant 
association of autophagy-related processes, including mTOR signaling, with the proteome 
of EVs from IAV-infected cells (study III, fig. 2). This raised a possibility that IAV might 
interfere with autophagy pathway, to modulate EV proteome. Indeed, among the 
identified proteins we identified numerous autophagy-related proteins in the sample 
derived from infected cells, including Golgi-associated plant pathogenesis protein 1 
(GAPR1, study III, fig. 5A). Silencing of GAPR1 with siRNA approach lead to marked 
decrease in EVs release upon IAV infection (study III, fig. 5B). 
We analyzed the proteins whose EVs association may be differentially regulated 
upon IAV infection. For this we extracted proteins that were identified only on EVs from 
IAV-infected macrophages and compared the identification scores from two biological 
replicates. Among the differentially secreted proteins we identified fatty acid-binding 
proteins (FABP3, FABP4, FABP5), ubiquitin pathway proteins (UBE2N, UBE2L3, 
RNF213, UBE2D3), translation-related proteins (EIF4A2, EIF5A, EIF6) as well as 7 
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members of copper metabolism gene MURR1 domain (COMMD) family (study III, fig. 4 
and Table 1). 
Fatty acid-binding proteins comprise a family of ten small proteins expressed in 
various tissues and involved in lipid transport. They have been found to play important 
roles in metabolic diseases, but their importance has also been noticed in immune 
responses (Hotamisligil and Bernlohr, 2015). Secretion of fatty acid-binding proteins 
was analyzed in detail. Secretion of FABP3 and FABP5, which were identified on IAV-
EVs but not on control EVs, was found to be induced by IAV infection. Immunoblot 
analysis confirmed the presence of FABP3 and FABP5 also on the purified EVs (study 
III, fig. 4). 
In addition to human proteins incorporated in the EVs, our analysis identified 
influenza-derived proteins in analyzed EVs samples from infected cells. These included 
hemagglutinin, neuraminidase, nucleoprotein, non-structural protein 1, matrix protein 1, 
polymerase acidic protein, polymerase basic protein 1, polymerase basic protein 2, matrix 
protein 2, RNA-directed RNA polymerase and nuclear export protein (study III, 
supplementary table 1). 
 
5. Analysis of DAMP secretion by activated human macrophages (I, II, III). 
 
Protein-mediated danger signaling has been studied in many analyses involving 
innate immunity cells and other (reviewed in Bianchi, 2007, Fleshner, 2013, Richmond 
et al, 2013, Tolle and Standiford, 2013). Many DAMPs lack the signal sequence and are 
known to be secreted via unconventional means (Bianchi, 2007). We thus decided to 
investigate DAMP secretion from human macrophages in total secretome (study II) and 
EV fraction (studies I and III) (Table 3) and to verify DAMPs not previously known to be 
EV-associated by checking their presence in Vesiclepedia. SignalP was used to predict 
the presence of N-terminal signal sequence. 
Our proteomic analyses of EVs identified many proteins linked with danger 
signaling both in total secretome (study II) and purified EVs (studies I and III). In studies 
II and III many of the identified proteins were detected only in stimulated samples. 
iTRAQ relative quantification ratios obtained in the study I corroborate the observed 
induction of DAMP secretion as demonstrated by iTRAQ ratio curdlan : control above 1 
in most cases (Table 3). 
 
UniProt 
Accession 
No 
Protein name study I study II study III Signal 
peptide iTRAQ ratio 
curd:control 
control 
secretome 
ATP 
secretome 
control 
EV 
IAV 
EV 
P04083 Annexin A1 1.5-3.4 + + + + no 
P07355 Annexin A2 1.5-4.3 + + + + no 
P12429 Annexin A3 - - - + - no 
P09525 Annexin A4 1.7 - + + + no 
P08758 Annexin A5 1.7-3.8 + + + + no 
P08133 Annexin A6 1.5-3.8 - + + + no 
P20073 Annexin A7 1.9-3.8 - - + + no 
P50995 Annexin A11 1.8-3.5 - + + + no 
P09382 Galectin-1 1.6-3.3 + + + + no 
P17931 Galectin-3 2.3 + + + + no 
P47929 Galectin-7 0.1 - - + + no 
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O00214 Galectin-8 - - - + + no 
O00182 Galectin-9 1.6 + + + + no 
Q3B8N2 Galectin-9B - - - + + no 
P26447 Protein S100-A4 1.6 + + + + no 
P25815 Protein S100-P - - - + - no 
P06703 Protein S100-A6 1.6-3.6 + + + + no 
P31949 Protein S100-A11 0.9-3.2 + + + + no 
P05109 Protein S100-A8 0.8-2.4 + + + + no 
Q86SG5 Protein S100-A7A - - - + + no 
P06702 Protein S100-A9 - + + + + no 
P60903 Protein S100-A10 1.6-2.8 - + - + no 
P04792 Heat shock protein 
beta-1 
1.2 + + + + no 
P34932 Heat shock 70 kDa 
protein 4 
- - + + + no 
Q92598 Heat shock protein 
105 kDa 
- + + + + no 
P11142 Heat shock cognate 71 
kDa protein 
1.7-2.7 + + + + yes 
P08107 Heat shock 70 kDa 
protein 1A 
1.2-3.1 + + + + no 
P07900 Heat shock protein 
HSP 90-alpha 
2.0 + + + + no 
P08238 Heat shock protein 
HSP 90-beta 
1.5-4.2 + + + + no 
P10809 60 kDa heat shock 
protein, mitochondrial 
- + - + + no 
P11021 78 kDa glucose-
regulated protein 
1.9-3.2 + - + + no 
P48723 Heat shock 70 kDa 
protein 13 
- - - - + yes 
Q12931 Heat shock protein 75 
kDa, mitochondrial 
- - - - + no 
P61604 10 kDa heat shock 
protein, mitochondrial 
n/d + - - + no 
P14625 Endoplasmin 2.0 - + + + yes 
P49913 Cathelicidin 1.6-1.85 + + + + yes 
P59666 Defensin alpha 3 1.7-6.3 - - - - yes 
P12724 Eosinophil cationic 
protein 
- - - - + yes 
P19338 Nucleolin - + + - + no 
P62328 Thymosin beta-4 1.5 - + - + no 
P63313 Thymosin beta-10 - - - - + no 
P02751 Fibronectin 0.4-1.4 - - + + yes 
 
Table 3. Protein DAMPs identified on EVs in studies I and III. “-“ protein was not identified, 
“+” protein was identified in at least one biological replicate. For study I the range of iTRAQ 
relative quantification ratios (curdlan : control) among three biological replicates is 
presented. Bold indicates statistically significant quantification in particular experiment, 
“n/d” indicates protein that was identified but the relative quantification was not determined 
due to too few peptides identified. Predicted signal sequence is indicated. All the proteins 
were previously found on EVs. 
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The analysis showed secretion of many previously described danger signal proteins 
in all three studies. Our analysis confirmed that DAMPs are recruited to EVs (studies I 
and III). Majority of identified proteins did not contain predicted signal sequence. 
Moreover, the recruitment of several DAMPs may be differentially regulated by 
macrophage activation, as indicated by the fact that they are identified only on EVs from 
stimulated cells and not from the control cells. Notably, all identified DAMPs have been 
previously identified on EVs and are reported in Vesiclepedia. 
 
5.1 Cytokines with key roles in viral infections are present in EVs from IAV-infected 
macrophages (III). 
 
Cytokines play essential roles in the regulation of immune response. Influenza-
infected macrophages are known to respond to viral infection by robust cytokine 
secretion, especially interferons, which play critical roles in antiviral defense. Numerous 
essential cytokines are not secreted by classical secretory pathway, hence we were 
interested in seeing if their secretion is associated with EVs in the course of IAV 
infection. 
Our proteomic experiments identified several cytokines and chemokines essential for 
antiviral defense. Their secretion on EVs was specifically dependent on IAV-infection 
(Table 4). 
 
UniProt 
Accession No 
Protein name (Gene name) control 
EV 
IAV EV 
P01375 Tumor necrosis factor (TNF) - + 
P05231 Interleukin 6 (IL6) - + 
Q14005 Interleukin 16 (IL16) - + 
Q14116 Interleukin 18 (IL18) - + 
P01562 Interferon alpha-1/13 (IFNA1) - + 
P01574 Interferon beta (IFNB) - + 
P01570 Interferon alpha-14 (IFNA14) - + 
P02778 C-X-C motif chemokine 10 (CXCL10) - + 
Q9H2A7 C-X-C motif chemokine 16 (CXCL16) - + 
 
Table 4. Cytokines and chemokines identified on EVs from control and IAV-infected cells in 
the study III. 
 
 
Thus the proteomic analysis confirms that several cytokines and chemokines 
produced by macrophages are secreted by unconventional, vesicle-dependent mechanisms 
in the course of IAV infection. 
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Discussion. 
 
Innate immune system evolved to protect the human from pathogens surrounding us 
continuously during our lives. Cells of the innate immune system are involved in constant 
detection and elimination of invading pathogens by phagocytosis, at the same time being 
capable of alarming the body and triggering adaptive immune responses. Innate immunity 
research has a rich history of notable discoveries starting from discovery of phagocytosis 
by Ernst Haeckel, through groundbreaking studies on macrophages by Elie Metchnikoff 
in late XIX century, to dissecting of molecular mechanisms governing pattern recognition 
by Bruce Beutler and Jules A. Hoffmann, later awarded the Nobel Prize in Physiology or 
Medicine in 2011. 
Macrophages are cells lying in the front of innate immune responses, constantly 
probing the surrounding by phagocytosis in search for pathogens that enter the tissues. 
Their activation by PRRs sensing PAMPs and DAMPs activates protein secretion 
responses, aiming at driving the subsequent innate and adaptive immune cells and 
signaling the potential danger. After the threat is cleared, macrophages are also essential 
for the final “clean-up” and homeostasis restoration after the danger is averted. 
Regulated protein secretion from innate immune cells, including macrophages, is a 
critical mechanism of intercellular signaling, activation of target cells, alarming about 
danger and coordinating responses throughout the system. Recent 20 years have provided 
mounting evidence that extracellular vesicles (EVs) lie in the core of the process of 
protein secretion from immune cells and participate in protein, RNA and DNA transfer, 
antigen presentation, receptor activation and many other processes associated with 
immune responses. Therefore, identification of proteomic composition and prediction of 
novel roles of EVs in the context of innate immune responses is of high interest from the 
immunological point of view. 
Importance of vesicular-mediated transport of biological molecules was also 
acknowledged, somewhat coincidentally with the prize for the discoverers of pattern 
recognition, by awarding James E. Rothman, Randy W. Schekman and Thomas C. 
Südhof the Nobel Prize in Physiology or Medicine in 2013, for their discoveries of 
machinery regulating vesicular traffic. 
The scientific importance of abovementioned discoveries turned the attention of 
biological researchers towards studying the EVs secretion in exciting new contexts, not 
only in the field of immunology. 
 
1. EV-mediated protein secretion in macrophage responses. 
 
The primary aim of this thesis was to analyze the unconventional, vesicle-mediated, 
protein secretion in human macrophages using high-throughput proteomic techniques. In 
the studies we relied both on quantitative proteomic approach (iTRAQ), which identifies 
and quantifies proteins from different samples simultaneously (study I), and comparative 
proteomic analysis (studies II and III), where proteomic composition of two independent 
samples (control and stimulated) is determined. 
Previous proteomic reports on human macrophage responses to viral infections 
(Lietzén et al, 2011, Miettinen et al, 2012), danger signals (Välimäki et al, 2013) and β-
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glucans (Öhman et al, 2014) indicated strong activation of overall protein secretion that 
was predicted to be mediated via different mechanisms. These proteomic analyses of 
secretomes revealed that most proteins identified in the culture medium are not classically 
secreted, suggesting significant contribution of unconventional, vesicle-mediated 
mechanisms to total protein secretion. Studies presented here provide an extrapolation of 
the previous reports on macrophage secretomes into EVs area. The data also collectively 
demonstrates robust activation of EVs secretion upon different, unrelated immunogenic 
challenges, indicating a perhaps general phenomenon in the process of macrophage 
activation. 
β-glucan, a fungal PAMP, is a well-known activator of innate immunity, triggering 
dectin-1-mediated responses (Brown and Gordon, 2001). Dectin-1 is a well-studied 
member of broader family of NK-cell-receptor-like C-type lectin-like receptors. Upon 
recognition of β-glucan structures it conducts a signal via Syk tyrosine kinase activating 
CARD9/MALT1/Bcl10 and canonical NFκB pathway (Gross et al, 2006). In addition to 
this pro-inflammatory signal, dectin-1 has also been shown to regulate respiratory burst 
and phagocytosis (Brown, 2006). The data presented here (study I) demonstrates that 
dectin-1-mediated stimulation of human primary macrophages with β-glucan curdlan 
induces significant activation of EVs secretion. Observation of vesicles of broad range of 
sizes (both smaller than 50 nm and larger than 200 nm) is indicative of presence of both 
exosomes and microvesicles in analyzed samples. Indeed, the EVs isolation protocol 
applied in the current studies did not aim at separation of larger vesicles from the 
exosomal pool. Supporting this, the proteomic analysis of EVs performed in the study I 
lead to identification of many membrane-associated proteins abundant in macrophages. 
These included a range of integrins and receptors essential for macrophage signaling that 
are normally exposed on the cell surface. Among those, many identified proteins have 
previously been identified as macrophage “signature proteins” (Becker et al, 2012). 
Apparent enrichment of surface membrane-bound proteins suggests that observed 
vesicles are released by surface shedding rather than via MVBs, although understanding 
the participation of different EVs secretion routes would require further studies. 
Quantitative proteomic analysis performed in the study I confirmed induced 
secretion of EV-associated proteins. This was indicated by the mass spectrometry data 
analysis software which indicated the 1.7-3.4-fold overall increase in total protein content 
of the EVs pool from curdlan-stimulated cells as compared with unstimulated cells. These 
data were in agreement with NTA analysis, which indicated a similar increase in extent of 
vesiculation (Figure 8). In summary, the study demonstrates that β-glucan stimulation of 
human macrophages activates EVs secretion. It was previously noted that 18 h curdlan 
stimulation of human monocyte-derived macrophages leads to 2.7-fold induction of 
overall protein secretion, with more than 70 % of secreted proteins lacking signal 
sequence (Öhman et al, 2014). Our data corroborates this observation, demonstrating 
that the unconventional mechanisms of secretion are activated during β-glucan challenge. 
Previous analysis of β-glucan-mediated activation of human macrophages 
demonstrated the importance and potential of dectin-1-mediated signaling in strong 
inflammatory response, involving NLRP3 inflammasome activation and robust secretion 
of pro-inflammatory cytokines (Kumar et al, 2009, Kankkunen et al, 2010). This 
capacity to fully extend the activation of inflammatory response without the need for co-
stimulatory factors suggests that β-glucans are potent and independent activators of 
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different cellular responses. Inflammasome has also been shown to be essential for 
protein secretion upon dectin-1-mediated activation (Öhman et al, 2014). Although it 
was not determined experimentally here, it is likely that the inflammasome activation is 
also involved in activation of vesiculation, as was earlier determined by Qu and 
colleagues in murine macrophages (Qu et al, 2007). 
Similarly to dectin-1-mediated response, we observed strong activation of EVs 
release upon macrophage treatment with other studied stimuli. Infection with influenza 
(study III) triggered significant vesicle secretion within 9 h post-infection. Proteomic 
analysis of purified EVs allowed for identification of almost twice the total number of 
proteins released from infected than from unstimulated human macrophages (study III, 
fig. 1). Importantly, many proteins were identified specifically associated with infected 
state. These observations strongly support the hypothesis that EV-mediated protein 
release is influenced by co-existing influenza infection. It was suggested that infection of 
HeLa (epithelial) cell line with IAV inhibits the conventional secretory pathway (Henkel 
and Weisz, 1998). Hence, shifting towards bulk, EV-mediated protein release might be a 
sign of regulated antiviral response aiming at counteracting the observed inhibition of 
secretory pathway. 
Several previous reports linked viral infection to EVs secretion and modulation of 
EV cargo proteome. Using SILAC approach Zhao and colleagues demonstrated that EV 
proteome changes upon HBV infection in hepatoma cell line (Zhao et al, 2014). Meckes 
and co-workers observed similar phenomenon in B cell-derived EVs from cells infected 
with gamma herpesvirus (Meckes et al, 2013). In light of these discoveries, modulation 
of EV proteome by IAV infection appears as rational explanation for differences in EV 
proteomes observed in the study III. As a proof of this concept, we demonstrated by 
proteomic analysis and confirmed with immunoblotting that FABP3 and FABP5 
preferentially associate with EVs released by infected cells, but not by unstimulated cells 
(study III, fig. 4). 
Using high-throughput proteomic analysis we identified IAV-derived proteins in 
purified EVs from infected cells. One explanation for this observation is potential 
regulated hiding of the viral structures inside EVs to protect them from immune 
detection. Similar mechanisms have been implied in virus spreading before (reviewed by 
Meckes, 2015). Supporting this theory, we identified numerous autophagy-related 
proteins and observed that silencing of autophagy-related GAPR1 protein results in the 
inhibition of EVs release. It was noticed earlier observations that IAV interferes with 
autophagy (reviewed by Zhang et al, 2014). It has also been suggested that IAV may 
hijack autophagosomal membranes arresting their fusion with lysosomes, instead 
directing them to fusion with plasma membrane and virion budding (Beale et al, 2014). 
This raises a possibility that secretory autophagy may participate in the EV-associated 
IAV release, consequently leading to recruitment of autophagosomal membrane proteins 
to secreted EVs. 
Although exciting, this observation must be interpreted cautiously. Despite the fact 
that EM analysis of isolated EVs did not indicate presence of entities resembling virions 
(Figure 9) and that IAV infection using investigated virus strain is non-productive in 
human macrophages, it was not possible to unambiguously determine with the applied 
methodology whether the sample is free of influenza virions. Validation whether 
incorporation of viral proteins to EVs is associated with membrane hijack or co-
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purification of the virus during ultracentrifugation would require alternative approaches, 
e.g. based on immunoaffinity (Cantin et al, 2008, Meckes and Raab-Traub, 2011). 
In contrast to studies I and III that investigated EVs secretion based on purified 
vesicle fractions, in study II we analyzed total protein secretion upon 15 min of ATP 
treatment. ATP triggered robust protein secretion, and using proteomic approach we 
identified double number of proteins in the secretome of stimulated cells as compared to 
control secretome (study II, fig. 1A). Signal sequence analysis of secreted proteins lead to 
recognition that EV-mediated secretion is the most likely mechanism of protein release 
upon ATP challenge (study II, fig. 1A). Indeed, further analysis showed strongly induced 
EVs secretion to the secreted medium (study II, fig. 1C).  
Robust activation of vesicle release by extracellular ATP has been observed before 
in different cell models (MacKenzie et al, 2001, Bianco et al, 2005, Pizzirani et al, 
2007, Qu et al, 2007) and is likely triggered by rapid increase in cytosolic calcium 
concentrations which causes cytoskeleton reassembly, phosphatidylserine translocation to 
outer phospholipid layer and consequent membrane bud formation (Campbell et al, 
2014). Similar phenomenon of EVs release was observed with other ionophores, e.g. 
monensin (Savina et al, 2003). Although the molecular signaling leading to the EVs 
release upon P2X7 activation is still a matter of debate, it is likely different than 
vesiculation of cells activated with fungal DAMPs or IAV.  
ATP-mediated EVs release was completely independent of the PRR-mediated 
activation, as LPS pre-treatment had no effect on ATP-induced EVs secretion (study II, 
fig. 6). It was previously reported that LPS treatment of human macrophages is a potent 
transcription activator, but does not trigger significant unconventional protein secretion 
on its own (Öhman et al, 2014). Our observations support the hypothesis that the ATP-
mediated vesicle secretion activation is an independent process of rapid release of danger 
signals and cytokines during immune challenge, and might assist in mounting further 
responses. However, the almost instantaneous release of EVs suggests that specific, 
targeted recruitment of their cargo is unlikely. Instead, the P2X7 activation probably 
gives a “go” signal for unconventional secretion of proteins whose synthesis and 
preparation for release was mediated earlier by other means. Analysis of secretome 
modulation by β-glucans and IAV infection suggested much more gradual EVs release. 
Noteworthy, also the fold increase in vesiculation is much higher when ATP is used, as 
compared with other studied stimuli (200-fold versus 3-27-fold). 
Together, presented studies indicate the importance of EV-mediated secretion from 
human macrophages in the context of innate immune responses. Three unrelated stimuli 
were found to increase EV-mediated secretion. In line with these observations, earlier 
study also demonstrated activation of protein secretion from human macrophages infected 
with herpes simplex virus 1 identifying primarily unconventially-secreted proteins 
(Miettinen et al, 2012). These observations raise the possibility that EVs secretion is a 
conserved mechanism of protein release and signaling in macrophage-mediated innate 
immune responses, although the mechanisms of formation of EVs and release and signals 
involved may differ. Further analysis is required to dissect the molecular networks 
guiding the EVs secretion in response to the analyzed stimuli. 
Studies presented in this thesis investigate the EV-mediated proteins secretion with 
two, fundamentally different proteomic approaches and utilize two different mass 
spectrometer setups. The scope of study I was to apply iTRAQ-based relative 
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quantification of vesicular protein release. iTRAQ analysis does not identify proteins 
independently in different analyzed samples. Instead, the approach relies on identification 
of pooled, differentially labeled proteins. Thus a relevant conclusion can be drawn from 
relative iTRAQ quantification ratios. The data from three biological replicates performed 
in study I indicated that EV-mediated secretion of all statistically significantly quantified 
proteins rises upon curdlan stimulation, indicating induced EVs release (study I, 
supplementary table 1 and Table 3). As opposed to this approach, in studies II and III 
identifications from control and stimulated samples are analyzed separately, allowing for 
direct comparison, but giving no direct quantitative data on relative protein release. 
Second important difference in the presented studies is the mass spectrometer used 
for analysis. Studies I and II took advantage of a hybrid quadrupole time-of-flight mass 
analyzer, while in study III a hybrid quadrupole-orbitrap mass analyzer was used. The 
latter offers higher accuracy, better resolving power and better sensitivity. These factors 
combined allow for lowering the threshold for detection and identification of very low 
abundant proteins. This fundamental advantage is the primary reason for significantly 
higher numbers of total identifications in the study III as compared with studies I and II 
(Figure 7). This also explains the identification of proteins that are present in EVs in 
extremely low amounts, like cytokines (Table 4) in the study III. 
 
2. Characterization of ATP-mediated protein secretion, inflammasome activation 
and roles of calpains in the process. 
 
Calpains are Ca2+-dependent cytosolic cysteine proteases with broad and poorly-
defined specificity (Sorimachi et al, 2012). Calpains have been shown to translocate to 
membrane compartment upon activation (Goll et al, 2003) and their roles in cleaving and 
remodeling cytoskeleton have been observed before (Lebart and Benyamin, 2006). 
Although the mechanisms of calpain-mediated proteolysis are similar across the family, 
different calpains are believed to be independently regulated and the cellular signaling 
leading to their activation is still a matter of debate (Ono and Sorimachi, 2012).  
Calpains have been studied also in the context of immune responses. Recent report 
investigated the roles of calpains in influenza infection of human bronchi epithelial cells 
(which is also associated with Ca2+ influx), showing that inhibition of calpains limits the 
secretion of pro-inflammatory cytokines IL-8, IL-6, RANTES and IFN-β in infected cells 
and impairs viral replication, suggesting roles of calpains in NFκB signaling (Blanc et al, 
2016). This supports the role of calpains as versatile regulators of cellular responses to 
immune challenges. 
The results of study II provide further insights into calpain roles in immunity. 
Extracellular ATP is one of the most ancient and evolutionary conserved DAMPs known 
for inducing various strong inflammatory responses at millimolar concentrations. Sensing 
extracellular ATP is achieved by the family of purinergic ion channels, including P2X7 
which upon activation triggers calcium influx and potassium efflux. Potassium efflux is a 
primary trigger of subsequent NLRP3 inflammasome activation (Muñoz-Planillo et al, 
2013), however some studies also indicated the importance of calcium signaling in this 
process (Murakami et al, 2012, Lee et al, 2012). It is currently speculated that 
inflammasome signaling might be cell model-specific (Katsnelson et al, 2015, Vaeth et 
al, 2015). Our data indicate that calpain activity is required for correct NLRP3 
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inflammasome assembly and secretion of IL-1β during response to extracellular ATP in 
human macrophages. 
ATP is a well-known activator of EVs release. In the study II we observed that the 
EVs secretion from ATP-stimulated cells was completely abrogated in the presence of 
calpain inhibitor MDL28170, demonstrating yet another role for calpains – regulation of 
ATP-induced vesiculation in human macrophages. Similar observation of the critical 
calpain functions was reported earlier in platelets. Croce and colleagues showed that 
calpains regulate multiple events associated with activation of human platelets, including 
secretion of granules, however they did not investigate the vesicle release directly (Croce 
et al, 1999). Another study demonstrated similar roles for calpains in mast cell 
degranulation (Wu et al, 2014). Given that calpains regulate vesicle release in various 
cell types and upon various responses, it is likely that the observed dependence of ATP-
mediated EVs secretion on calpains is a part of a much broader and more conserved 
spectrum of calpain activity, probably at the cytoskeleton level. 
Prolonged exposure of cells to ATP results in cell death. It was therefore important 
to establish that the observed calpain-dependent events were specifically associated with 
early P2X7-mediated signaling and not with cell necrosis and associated unspecific 
events. Our results indicate limited extent of cell death within 15 min of ATP exposure 
(<10 %, as measured by LDH assay, study II), demonstrating that inflammasome 
activation and EVs release is a regulated event preceding the cell death. Calpains have 
been suggested to be participating in signaling during insults leading to cell death 
(reviewed in Harwood et al, 2005), but their direct roles in EVs secretion remain poorly 
characterized. 
Together, this data indicates that during P2X7 activation by ATP, the calcium influx 
activates calpains in an early downstream signaling event. This was confirmed by 
observation that calpain inhibition did not prevent the P2X7-mediated calcium influx 
(study II, fig. 6). Calpains are known to be highly-dependent on intracellular calcium 
concentration, so the rapid rise in cytosolic calcium associated with P2X7 activation is 
likely the trigger for their activation.  
The presented results suggest that calpain activation downstream of P2X7 receptor 
signaling is a common checkpoint for two different responses associated with the ATP 
activation: inflammasome activation and pro-inflammatory cytokine processing on one 
hand, and rapid secretion of EVs on the other. This data sheds new light on those 
concurrent human macrophage responses to extracellular ATP-related danger signaling 
linking them with essential roles of calpains. 
 
3. Macrophage-derived EVs as important intercellular signal messengers. 
 
DAMPs comprise a heterogeneous group of biological compounds that activate 
danger responses in immune cells, especially inflammation. DAMPs, as opposed to 
PAMPs, appear in the circulation and local tissues as a result of damage or activation of 
healthy cells. Their release is often triggered during uncontrolled cell death, but cells of 
the immune system can secrete DAMPs in a controlled process (Bianchi, 2007). 
Numerous classes of biological substances have been linked with danger signaling, 
including protein and non-protein molecules. Some well-characterized non-protein 
DAMPs include extracellular ATP, ROS, uric acid and its crystals, heparan sulfate and 
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externalized DNA (Kaczorowski et al, 2012). DAMPs can activate innate immune 
system in a manner similar to PAMPs, and have been shown to trigger TLR signaling 
(Tolle and Standiford, 2013). 
Several protein families play important roles in danger signaling. S100 family of 
proteins has been associated with danger signaling. Best-characterized members of this 
family, S100-A8 and S100-A9, are produced by cells of myeloid origin. They have been 
found to activate TLR4 and RAGE-mediated signaling leading to NFκB activation and 
pro-inflammatory response (reviewed in Schiopu and Cotoi, 2013). Similarly to S100 
proteins, also heat-shock proteins have been implicated in TLR signaling (Schmitt et al, 
2007). Secretion of S100-A9 from macrophages has been shown to increase during IAV 
infection facilitating the pro-inflammatory response in mouse macrophages (Tsai et al, 
2014). In agreement with this, the data presented in study III indicates that S100-A9 is an 
EV-associated DAMP. Our data shows that macrophage-derived EVs may serve danger 
signaling purposes as they contain S100 proteins. 
The proteomic analysis of total secretome (II) as well as EVs fraction (I and III) 
revealed active secretion of DAMPs from human macrophages upon stimulation (Table 
3). As most DAMPs are not secreted through classical secretory route (Srikrishna and 
Freeze, 2009), their presence in both analyzed fractions is expected. 
In our secretome characterization we identified many DAMPs whose EV-mediated 
secretion is induced upon β-glucan activation (Öhman et al, 2014). We demonstrated 
that secretion of DAMPs (galectins, heat shock proteins, S100 proteins) is upregulated in 
response to curdlan, despite lack of signal peptide on most identified proteins. In the 
study I we confirm that the presence of many of them is associated with EVs, thus 
demonstrating the unconventional means of their secretion (see Table 3). 
The robust EV-mediated DAMP secretion is not uniquely associated with dectin-1-
mediated activation, as we show that these proteins are also present in the ATP-induced 
secretome and EVs from IAV-infected macrophages. The latter observation corroborates 
previous analysis of the total secretome of IAV-infected macrophages which also 
demonstrated the activation of DAMP release (Lietzén et al, 2011). It was shown that 
secretion of several major danger signal proteins (galectin-3, high mobility group box 
protein 1 and 2 (HMGB1 and 2), S100-A8, S100-A9) is strongly (2-5-fold increase) 
activated 6 h post-infection (Lietzén et al, 2011).  
In the studies II and III several DAMPs were detected only in the sample from 
stimulated cells and not from control cells (see: thymosin beta-4, protein S100-A10 in 
Table 3). This observation raises a possibility that secretion of certain DAMPs is not 
constitutive but rather regulated by macrophage activation in our model, similarly to 
FABP3 and FABP5 whose differential recruitment to EVs was demonstrated in study III. 
One of the key DAMP proteins implicated in leukocyte danger signaling, HMGB1, 
was not identified. Several previous studies reported identification of HMGB1 in 
association with EVs secreted from dendritic cells (Kowal et al, 2016), endothelial cells 
(de Jong et al, 2012) and colorectal cancer cells (Tauro et al, 2013). Detection of 
HMGB1 has been reported in the microvesicle fraction of ATP-stimulated macrophages 
before, although it was shown that its unconventional secretion is profoundly increased 
when the cells are primed with LPS (Thomas and Salter, 2010). The fact that in our 
analysis (study II) we did not prime the cells with LPS may thus serve as potential 
explanation for absence of HMGB1 on identification lists. 
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Apart from DAMPs mentioned above, secretion of cytokines and chemokines by 
macrophages is a well-studied phenomenon. Cytokines in particular play essential roles in 
coordination of immune responses. However, cytokines are secreted in minute amounts, 
what makes them difficult to detect in classical bottom-up proteomic approaches. Thanks 
to pre-analysis enrichment of the EVs sample and use of highly sensitive, orbitrap-based 
mass spectrometry approach we were able to detect several important cytokines and 
chemokines secreted in association with EVs from IAV-infected cells (study III table 1, 
see Table 4), thus confirming that EVs contribute to their unconventional secretion upon 
IAV infection. Several earlier studies demonstrated the presence of cytokines and 
chemokines on the EVs before (reviewed in Yáñez-Mó et al, 2015). Analyses of EVs 
from different cells confirmed the presence of IL-6 (Inder et al, 2011), TNF (Zhang et 
al, 2006), IL-16 (Prokopi et al, 2009, Kowal et al, 2016), IL-18 (Wang et al, 2012, 
Prunotto et al, 2013). However, to our knowledge, IFNs have not been previously 
identified in EVs. In our analysis we identified IFN-α1, IFN-α14, and IFN on EVs 
derived from IAV-infected cells. These cytokines (along with already mentioned IL-6 and 
IL-18) play essential roles in antiviral responses and were not detected on control samples 
in the study III. Presence of these key antiviral cytokines on EVs raises an exciting 
possibility of targeted delivery of intact and well-protected cytokines to recipient cells. It 
also suggests that EVs released from IAV-infected cells have antiviral properties. 
In line with the observed unconventional cytokine release, in the study I the 
bioinformatic analysis identified potential link of EVs with P2X7 receptor signaling and 
IL-1β secretion (study I, fig. 5). The data presented in the study I provides evidence that 
EVs participate in secretion of key pro-inflammatory cytokine IL-1β, however rather than 
mature 17 kDa protein, the 34 kDa pro-form is secreted. Multiple earlier studies reported 
association of mature IL-1β with the released vesicles. This phenomenon of 
unconventional secretion of both mature and pro-form of this key inflammatory cytokine 
has been intensively investigated in the context of P2X7-mediated shedding of membrane 
microvesicles (MacKenzie et al, 2001, Qu, et al, 2007, Pizzirani et al, 2007). Another 
IL-1 superfamily member, IL-18, has also been demonstrated to be released by vesicle-
mediated mechanisms (Gulinelli et al, 2012). However, not much is known regarding 
secretion of precursor forms of the cytokines. 
The reason for the EVs containing the IL-1β precursor is unknown. However, since 
β-glucans are known inducers of both translation of pro-form of cytokine and its 
processing, the possible explanation would be that the pro-IL-1β accumulates 
intracellularly at the proximity of cellular membrane and is non-specifically recruited to 
membrane-shed microvesicles before being processed by caspase-1, while mature IL-1β 
is targeted for release via distinct mechanisms. It has been suggested that vesicle-
mediated secretion of IL-1β provides a protection for the cytokine from rapid degradation 
in the plasma in the process of targeted delivery away from the inflammation site (Lopez-
Castejon and Brough, 2011). Perhaps enclosing the pro-form of the cytokine in 
membrane vesicles serves similar purpose for targeted delivery and subsequent 
processing of the cytokine in recipient cell. 
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Conclusions and future perspectives. 
 
Innate immune system serves as a first defense line against invading pathogens. 
Innate immune system is also a crucial link between quick and robust detection of 
emerging danger, limiting the spread of infection and activation of highly specific and 
targeted adaptive immunity. Innate immunity cells are diverse in their functions. Among 
them, macrophages lie in the front line of innate immunity, actively secreting proteins to 
coordinate immune responses to both external and internal danger. 
Extracellular vesicle release emerged recently as the mean for secretion of majority 
of proteins found in extracellular space. Enclosed behind lipid bilayer membrane, small-
sized and expressing numbers of proteins on their surface, EVs are equipped with all 
necessary means to deliver their cargo safely in a targeted manner. As it is now clear that 
most if not all eukaryotic cells secrete the EVs, it is important to continue investigation of 
their roles and biological potential. In particular, in the dynamic field of immunology, 
where multitude of different cells communicate and act in concert to serve their protective 
roles, EVs secretion attracts a lot of attention. 
The presented thesis penetrates the relatively unexplored field of EVs secretion by 
human macrophages during activation of immune responses. It is demonstrated that 
human macrophages activate robust EVs secretion during response to three different 
stimuli: β-glucan, an immunogenic fungal cell wall component, extracellular ATP, an 
endogeneous danger signal released from damaged tissues, and a pathogenic human 
influenza A strain. Observation that three stimuli, normally representing unrelated 
pathologic conditions, all induce EVs secretion in the studied cell model is an indication 
that in humans, macrophages utilize unconventional protein secretion means as a 
conserved mechanism of innate immune responses.  
Proteomic analysis remains a powerful method in the field of EVs analysis, allowing 
for detailed analysis of biologically significant EVs cargo. Proteomic studies performed 
in this work identified many novel proteins previously not linked with EVs. They also 
reveal that the secreted EVs carry important signaling proteins, including danger signals 
and cytokines. It is thus interesting to investigate these unconventional secretion means in 
the future. In particular, EV-associated cytokines may exert responses significantly 
different from their soluble counterparts, as they can be delivered to recipient cells and 
act only upon internalization of vesicles. It was shown before that ATP results in 
incorporation of IL-1β, the key pro-inflammatory cytokine, in the EVs. We demonstrate 
here that also (1,3)-beta-glucans lead to recruitment of this cytokine to EVs. Interestingly, 
however, it is the precursor form of IL-1β, and not the mature protein whose secretion is 
mediated by EVs. Whether delivery of the precursor to target cell would lead to the 
maturation of IL-1β remains to be tested, but this hypothesis is in agreement with the 
highly specific targeted action of cytokines and chemokines. 
Bioinformatic analysis is an indispensable element of modern high-throughput 
proteomic studies. Here, we used various bioinformatic prediction tools to identify 
relevant processes and cargo proteins in the studied vesicles. Biological pathway analysis 
was used to identify the roles of calpains, a group of cytosolic Ca2+-activated proteases in 
ATP-mediated activation through purinergic P2X7 receptor. It is shown here that the long 
known phenomenon of vesicle shedding in response to extracellular ATP is highly 
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dependent on calpains. Given that calpains are abundantly expressed and they have been 
shown to regulate multiple other signaling events, it is tempting to speculate that their 
role in EVs secretion has much more to reveal. Further analysis of calpain targets will 
allow for delineating signaling pathways and understand the observed dependence of EVs 
secretion and inflammasome activation on calpains in more detail. Importantly, the EVs 
secretion is not the only calpain-dependent effect. We demonstrate here that calpain 
activity is also required for ATP-triggered NLRP3 inflammasome activation and IL-1β 
secretion 
The presented work provides further insights in the roles of EVs secretion during 
viral infection. Macrophages infected with influenza A start secreting EVs in few hours 
post-infection. Using proteomic and bioinformatic approaches we identified that during 
the infection, macrophages not only induce the EVs secretion, but likely also modulate 
the vesicle composition by recruiting antiviral cytokines, danger signals and proteins 
known to interfere with translation process. Whether the latter is a result of the virus 
trying to inhibit the infected cell responses or an attempt to modulate gene expression in 
recipient cells remains to be investigated. 
The presented work identifies EVs secretion as a significant and common response 
during macrophage activation by widespread pathogenic and immunogenic activators. 
Proteomic approaches supported with in-depth bioinformatic analysis and functional tests 
shed new light on the roles the EVs play in the intercellular signaling and the cargo they 
convey. It can be concluded that the secreted EVs carry a cargo of proteins capable of 
activating other cells. As macrophages play important regulatory roles, EVs secretion 
appears as a previously unappreciated mechanism of the signal delivery to coordinate 
cellular immune responses. Future studies are needed to reveal the functional details of 
the EV-mediated signaling. In particular, these investigations should focus on modulation 
of cargo sorting to EVs upon cellular activation on one hand, as well as the biological 
impact of EVs uptake by recipient cells. This will allow for better and broader 
understanding of the biological roles that EVs play in the field of innate immunity. 
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Kornelia Mikuła, Alex Budria and Marcin Nagy. Each of you is special, each of you is 
different. Each of you had tought me to look at life from a different, better perspective. I 
learned a lot and I truly hope we continue this friendship. Wherever I will happen to be, 
the door of my house will remain open for you. 
 
Finally, I want to thank my biggest and unconditional supporters – my parents.  
Kochani Rodzice, te pięć z górą lat, pełnych dołków i wzniesień było niełatwą 
drogą. Dziękuję że nigdy nawet przez chwilę nie przestaliście wierzyć, że moment w 
którym dostaniecie na ręce tę pracę nadejdzie. Bez Waszego wsparcia nie nadszedłby. 
Jesteście najlepszymi rodzicami na świecie. 
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